Functional Coatings or Films for Hard-Tissue Applications

Wang, Guocheng; Zreiqat, Hala

doi:10.3390/ma3073994

Open AccessReview

Functional Coatings or Films for Hard-Tissue Applications

by

Guocheng Wang

and

Hala Zreiqat

^*

Biomaterials and Tissue Engineering Research Unit, School of AMME, The University of Sydney, Sydney 2006, Australia

^*

Author to whom correspondence should be addressed.

Materials 2010, 3(7), 3994-4050; https://doi.org/10.3390/ma3073994

Submission received: 4 June 2010 / Revised: 23 June 2010 / Accepted: 7 July 2010 / Published: 9 July 2010

(This article belongs to the Special Issue Advances in Surface Coatings)

Download

Browse Figures

Versions Notes

Abstract

:

Metallic biomaterials like stainless steel, Co-based alloy, Ti and its alloys are widely used as artificial hip joints, bone plates and dental implants due to their excellent mechanical properties and endurance. However, there are some surface-originated problems associated with the metallic implants: corrosion and wear in biological environments resulting in ions release and formation of wear debris; poor implant fixation resulting from lack of osteoconductivity and osteoinductivity; implant-associated infections due to the bacterial adhesion and colonization at the implantation site. For overcoming these surface-originated problems, a variety of surface modification techniques have been used on metallic implants, including chemical treatments, physical methods and biological methods. This review surveys coatings that serve to provide properties of anti-corrosion and anti-wear, biocompatibility and bioactivity, and antibacterial activity.

Keywords:

metal; corrosion; wear; bioactivity; biocompatibility; antibacterial; surface modification

Graphical Abstract

1. Introduction

Metallic biomaterials like stainless steel, Co-based alloy, Ti and Ti alloys are widely used as artificial hip joints, bone plates and dental implants due to their excellent mechanical properties and endurance [1]. However, long-term performance of surgical implants is directly depending on their surface properties. Most implanted metallic biomaterials have a tendency to lose electrons in solution and, as a result, they show a high potential to corrode in the biological environments, which usually cause inflammatory and loosening of the implants [2]. Additionally, their low surface hardness, high friction coefficient and poor wear resistance are also limiting their application of metallic biomaterials [3,4]. It is reported that wear and corrosion are the main reasons for degradation of surgical implants such as hip and knee joint implants, which usually happens after 10–15 years of use [4]. Another problem associated with metallic implants is their biological inertness. Bioinert materials are incapable of inducing positive connective osteogenesis or new bone ingrowth, thus only low fixation strength can be achieved between the implant and the host bone [5]. To protect the metallic implants from corrosion and wear and improve their bioactivity, tremendous surface modification techniques have been applied to deposit a great variety of functional coatings on the surfaces of metallic implants. As the implant-related bacterial infection remains a major impediment to the utility of medical implants despite of the use of sterilization and aseptic techniques, researchers are also endeavoring to develop coatings with antibacterial activity [6].

This review is aiming to give a comprehensive summary of these coatings. The outline of this paper is displayed in Figure 1. Since there have been already many review papers about the surface modification methods, this review primarily focus on the functions of the coatings as well as their influencing factors, instead of basic knowledge of surface modification techniques. For basic knowledge of the techniques mentioned in this article, readers can refer to related references cited there.

Figure 1. The outline of this review paper.

2. Anti-corrosion and Anti-wear Coatings

Metals are widely used as biomaterials due to their low thermal conductivity, high ductility and excellent combination of high strength and low modulus. Presently, the materials used for this application are 316 L stainless steel, cobalt chromium alloy, Ag, Au, and titanium-based alloys as well as magnesium alloys. Some of them are used as passive substitutes for hard tissue replacement such as total hip and knee joints, fracture healing aids as bone plates and screws, spinal fixation devices, and dental implants. Some other alloys are used for more active roles in devices such as vascular stents, catheter guide wires, orthodontic archwires, and cochlea implants [7]. There are also some metals for specialized implant application. For example, radioactive tantalum (Ta182) has been used to treat head and neck tumors [8].

However, most implanted metals, such as titanium, cobalt-chromium and stainless steels, have a tendency to lose electrons in solution and, as a result, they show a high potential to corrode. Corrosion is the unwanted chemical reaction, which can result in degradation of metal implants to oxides, hydroxides, or other compounds. These degradation products may cause a local inflammatory response, finally lead to the cessation of bone formation, synovitis, and loosening of artificial joint implants [2]. The service period of the material is mainly determined by its abrasion and wear resistance. The low wear resistance can lead to the formation of wear debris which may cause several reactions in the tissue in which they are deposited thus increasing failure probability of the implants. Another detrimental aftermath of metal corrosion and wear is that it can weaken an implant, causing premature failure [9]. Therefore, there is a significant need to design or invent metal implants with enhanced corrosion and wear resistance.

There are two usual ways to improve the corrosion and wear resistance of a metal implant. One is via bulk alloying and the other is via surface modification. Since this paper only focuses on surfaces of the metal implants, the former is not covered here. In this section, coatings for anti-corrosion and anti-wear are divided into several groups: oxide coatings; nitride coatings and diamond-like carbon coatings. The related surface techniques are also briefly introduced.

2.1. Oxide Coatings

2.1.1. Thermal oxidation technique (TO)

Thermal oxidation technique is a widely used novel surface engineering process to improve the anti-corrosion and anti-wear properties of Cp Ti and its alloy [10,11,12,13,14,15,16,17,18,19], based on thermochemical reaction. It is usually carried out in a controlled atmosphere containing oxygen and nitrogen at approximately 600 °C [18]. Borgioli et al. [13] successfully fabricated oxide layer on the Ti-6Al-4V by treating the Ti-6Al-4V in an air circulating furnace at 1173 K for 2 h at 105 Pa followed by quenching using compressed air. Wear tests, carried out on both untreated and oxidized samples in block-on-ring test configuration under dry sliding conditions, showed that thermal oxidation treatment was able to substantially improve the wear resistance of Ti-6Al-4V samples, reducing the wear volumes by about 4 to 6 times in comparison with the untreated alloy. The improved performance was due to the formation of the hard oxide layer and the oxygen diffusion zone (ODZ) beneath it [12]. The Vickers hardness was increased from 169 to 492 (100 g force) for Cp-Ti and 369 to 755 (100 g force) for Ti-6Al-4V after thermal oxidation treatment [12]. Both the oxide layer and ODZ contributed to the improvement of the wear resistance and the prevention from extensive corrosion-wear of the Ti-6Al-4V [12,19]. However, the oxide layer produced by thermal oxidation, especially at high temperatures (above 800 °C) and with prolonged soaking times, has a low bonding strength with the substrates and is inclined to debonding [20]. To solve this problem, cooling treatments with a very slow rate can be applied on titanium after thermal oxidization [10]. As far as biological properties, it was demonstrated that Ti and Ti-6Al-4V alloy showed improved biocompatibility after thermal oxidation [11,21].

2.1.2. Microarc oxidation (MAO)

Microarc oxidation, also called microplasma oxidation or anodic spark deposition, is a surface modification technology developed to produce hard, thick oxide coating on metallic substrates. Xue et al. [22] fabricated ceramic coatings on Ti-6Al-4V by micro-arc oxidation in aluminate solution. The coating was mainly composed of TiO₂ in rutile form and TiAl₂O₅ compounds. The content of TiO₂ increased from the surface to the interior of the coating while the TiAl₂O₅ was quite the reverse. Nanoindentation tests showed that the hardness was significantly improved by MAO and gradually increased from the surface to the interior consistent with the variation of TiO₂ fraction along the coating thickness. The kinetics of MAO coatings is interface-controlled and largely dependent on the applied current density and treatment time [23,24].

Besides Ti and Ti alloys, MAO has been also widely used on magnesium alloy to protect it from corrosion and wear [24,25,26,27,28]. The corrosion resistance of AZ91D magnesium was improved over 100 times after MAO treatment in solution containing aluminate and potassium fluoride at constant applied current densities, due to the formation of the ceramic coating composed of spinel MgAl₂O₄ phase and intermetallic Al₂Mg phase [25]. However, MAO coating generally possesses a foam-like structure with high bulk porosity, which is undesired in anti-corrosion and anti-wear applications. The work done by Guo et al. [29] showed that the addition of surfactants in the electrolyte could successfully inhibit the generation of pores within ceramic coatings, thus improving the coating quality. Silicate and phosphate electrolytes are also often used in MAO process, as coating fabricated from both these two electrolytes could protect magnesium from corrosion and wear [28,30,31]. But coatings formed from silicate solution showed better anti-corrosion ability than that from phosphate solution due to their different phase composition and coating structure [28,30]. Coatings formed from silicate electrolyte are usually compact and are mainly composed of Mg₂SiO₄ and MgO, while coatings from phosphate are relatively porous and are mainly composed of MgO.

2.1.3. Oxygen ion implantation

Oxygen ion implantation can also be used to improve the wear and corrosion resistance as well as biocompatibility of the metallic materials. Ion implantation includes conventional beam-line ion implantation and plasma immersion ion implantation (PIII). In the conventional beam-line ion implantation, an ion source is used to create an ion beam of the species to be implanted, and then the ion beam is accelerated through high potential and bombarded into the substrates. It is a line-of-sight process so that the objects must be correctly manipulated to get the desired surface implanted. PIII initially developed by Conrad can circumvent the beam line restrictions and does not require the manipulation of the substrates [32]. It has been widely used to improve the surface properties of biomedical metal materials, such as wear resistance, corrosion resistance and biocompatibility.

Leng et al. [33] demonstrated that plasma immersion ion implantation of titanium and oxygen on Ti-6Al-4V greatly improved the wear resistance of the Ti-6Al-4V under low load. The hardness of the newly formed TiO_x film increased with increasing oxygen partial pressure in the range of 0–3 × 10^-2 Pa, and reached the maximum of 17 GPa at an oxygen partial pressure of 3 × 10^-2 Pa. However, the thickness of the films was suboptimal for this application. The thickness of the surface layer was observed to depend on the implantation temperature and treatment time [34]. At low temperature, oxygen does not adequately diffuse into the bulk material thus limiting the layer thickness. For NiTi alloys, Tan et al. [35] demonstrated that the thickness of the oxide coating using oxygen implantation was influenced by the austenite finishing transformation temperature (A_f). In their work, aging treatments followed by quenching were performed on commercial Ti-50.7 at.% Ni alloys before ion implantation. The A_f of sample treated at 550 °C for 20 min and 400 °C for 70 min were −3° and 21°, respectively. The oxide thickness was found to be 1,140 nm for A_f = 21° samples which was 370nm higher than that of A_f = −3° samples. One reason for this was thought to be the different holding time at elevated temperature. Additionally, the presence of martensite increased the average oxygen penetration because this phase was dilated with respect to austenite. The fact that samples with A_f = 21° are more inclined to experience austenite-to-martensite phase transformation near room temperature, might be another important reason for the thicker oxide on the samples [35]. Their further study showed that samples with A_f = 21° and oxygen implanted at a dose of 1 × 10¹⁷ ions/cm² had the best pitting corrosion resistance. Increasing the oxygen dose to 3 × 10¹⁷ ions/cm² resulted in the formation of nano pores which impaired the pitting corrosion resistance [36]. Fretting wear tests followed by measuring the wear scar volume showed that oxygen implantation improved the wear resistance of NiTi alloys [37].

2.1.4. Sol-gel method

Sol-gel derived oxide films or coatings like SiO₂, Al₂O₃, TiO₂ and ZrO₂, can be also deposited on the metals to improve their resistance to corrosion and wear. The sol-gel process, also known as chemical solution deposition, is a wet-chemical technique, a process involving five main steps: (1) hydrolysis and polycondensation; (2) gelation; (3) aging; (4) drying; (5) densification and crystallization. Compared to conventional thin film processes, sol-gel process allows for better control of the chemical composition and microstructure of the films utilizing simple equipments at low cost. Especially, the heat treatment temperature it needs is lower because precursors can be mixed at molecular level in the solution and thus a high degree of homogeneity can be obtained in the films.

Sol-gel thin coatings of ZrO₂, SiO₂, 70SiO₂-30TiO₂ and 88SiO₂-12Al₂O₃ composition ( mol %) have been prepared from sono-catalyzed sols and deposited by dip-coating technique on 316 L stainless steel foils [38]. All of the coatings resulted in a lower corrosion rate compared to the uncoated samples. Liu et al. [39] deposited TiO₂ coatings on NiTi alloy using sol-gel method and compared their corrosion resistance and blood compatibility to the uncoated sampled. The coating was 205 nm in thickness and mainly composed of rutile TiO₂ after sintered at 500 °C. Electrochemical tests on the coated and uncoated NiTi alloys in Tyrode’s solution showed an increase in the breakdown potential (E_b) by 200 mV and a decrease in the passive current density (i_p), indicating the improved corrosion resistance of the NiTi alloys by TiO₂ coating. Furthermore, blood compatibility of the coated NiTi alloy was also superior to the uncoated metal. Tribological behavior of sol-gel TiO₂ film on a glass substrate was studied by using a reciprocating friction and wear tester sliding against Si₃N₄ ball and AISI52100 steel [40]. It was demonstrated that the friction of the glass was highly reduced after coated with TiO₂ film. A slight plastic deformation of the film and its good adhesion to the substrate were thought to be the main reasons for its improved wear resistance. Jia et al. [41] found that adding suitable amount of SiO₂ to TiO₂ films improved anti-wear and friction-reduction performance of TiO₂ film, which was ascribed to the reduction in TiO₂ grain size, the increase in adhesion strength and the formation of Si-O-Ti hetero-linkages. Consequently, the wear mechanism changed from plastic deformation and abrasive wear to light scuffing and abrasion, which was the same as the sol-gel TiO₂ films with well-dispersed Ag particles [41]. However, it was not the case when the SiO₂ film was used alone or as an interlayer, instead of as a dopant. Zhang et al. [42] systematically studied the anti-wear properties of SiO₂, TiO₂ and hydroxyapatite (HA) films on Ti-6Al-4V prepared by sol-gel methods. The wear resistance of SiO₂ was the worst both under low load (1 N) and high load (3 N). However, a worthy finding was that sol-gel HA films had the best wear resistance under both low and high load. Their further study on TiO₂, SiO₂, HA, TiO₂-HA and SiO₂-HA thin films showed that the wear resistance of the HA dual films (TiO₂–HA and SiO₂–HA) deteriorated both under 3 N and 1 N due to residual stress in the dual films caused by the difference of thermal expansion coefficient between HA and TiO₂ or SiO₂ [43]. But under 0.5 N loads, a longer wear life was obtained for TiO₂-HA films, due to the insufficiency of the load to induce the release of the internal stress between the films. Besides the TiO₂, ZrO₂, SiO₂ and HA mentioned above, Al₂O₃ sol-gel films also showed good wear resistance, but are rarely used as anti-wear coating for biomedical metal due to its possible cytotoxicity [44].

2.1.5. Thermal spraying technique

Thermal spraying is also a useful coating technique for enhancing the corrosion and wear resistance of biomedical metallic implants. Briefly, thermal spraying is a process in which melted or semi-melted particles are sprayed onto a substrate surface. It can be divided into many categories according to energy sources used for heating or melting the powder particles, such as plasma spraying, flame spraying, high velocity oxy-fuel spraying, arc spraying and so on.

Due to its capacity for ultrahigh temperature heating and fabricating components with alternate layers of different material composition as well as low operating and capital cost, plasma spray has drawn lots of attentions in many fields. A wide variety of ceramic coatings, such as Cr₂O₃-SiO₂-TiO₂, Cr₂O₃, Cr₂O₃-Ni-Cr, WC-Co, TiO₂, ZrO₂, Al₂O₃ and like that, have been studied on their tribological properties [45]. However, only TiO₂ [46,47], Al₂O₃ [48] and ZrO₂ [49] coatings have been tried to be used as biomedical coating due to their good biocompatibility. The recent progress in plasma sprayed anti-wear coatings are summarized as follows:

A: Composite with other materials: Al₂O₃ is an attractive material for wear-resistance due to its high hardness and high thermal conductivity. However, brittleness is its main problem limiting its application in some fields. The addition of TiO₂ and ZrO₂ can improve the fracture toughness of Al₂O₃ but also lower its hardness [50,51]. Optimizing the appropriate proportion of alumina and zirconia to achieve a composite with improved wear resistance remains to be a challenge.
B: Nanostructured coatings: Grain size is another important factor influencing the wear resistance of materials. The relationship between wear resistance and the grain size follows the type of Hall-Petch law [52]. When the grain size is reduced to nanosize, higher external stress is required to induce grain boundary cracking and pulling-out of grains, hence, the nanostructured coatings shows better plastic deformation ability than traditional coating during sliding wear. Moreover, an improved hardness and toughness are also observed for the nanostructured coating [53]. Therefore, nanosized grains are expected to be able to improve the wear resistance of the coatings [54]. Chen et al. [55] compared the friction and wear properties of plasma sprayed nanostructured and conventional zirconia coating against stainless steel with a sliding, reciprocating and vibrating test machine under water-lubricated conditions. It was found that plasma sprayed nanostructured zirconia coatings possessed better wear resistance than traditional coatings in that the wear rate of the former was in the range from one-fourth to four-fifths of the latter under loads ranging from 20 to 50N. The great effects of nanostructured coating on wear resistance are also improved by other researchers using other coating systems like TiO₂ [47], Al₂O₃-ZrO₂ [56] and Al₂O₃-TiO₂ [57].
C: Post-treatments: There are two major problems with plasma spraying. The primary problem is the poor bonding strength between the coating and substrates, which causes the sprayed material to peel off under high bending stress. The second problem is the high porosity of the coating, which usually reduces the anti-corrosion and anti-wear performance. To overcome these drawbacks, post-treatments by laser are often used. Post-treatments like laser remelting can significantly reduce the porosity and roughness of plasma sprayed coating, and apparently improve the bonding strength, thus enhancing the wear resistance of the as-sprayed coating [58]. For plasma sprayed zirconia coating, laser remelting could change the main wear mechanism from spallation to ploughing and gouging [58]. For Al₂O₃-13 wt. % TiO₂ coating, the enhanced wear resistance after laser melting were ascribed to not only the improvement of the microstructures, but also the transformation from metastable phase γ-Al₂O₃ to stable phase α-Al₂O₃ [59].

2.2. Nitride Coatings

ZrN coating or film has been drawing attentions for its excellent erosion resistance, biocompatibility, high hardness, good lubricity and ductility. Its corrosion resistance has been studied on many different metal substrates, including AZ91 Mg alloys [60], Ni-Ti shape memory alloy [61], AISI 304 stainless steel [62] and Ti6Al4V alloy [63]. Table 1 is a summary of the anti-corrosion properties of ZrN coating or film deposited on different metal substrates using different methods.

Xin et al. [60] deposited ZrN/Zr coatings on biodegradable magnesium alloys using a filtered cathodic arc deposition system to inhibit its degradation in aqueous environment. Electrochemical tests in simulated body fluid (SBF) showed that the corrosion potential of the uncoated alloy was quite negative and only about −1830 mV while that of the coated alloy was much more positive, shifting to about −1420 mV. The corrosion current density of the coated alloy was also significantly improved, with about two orders of magnitude lower than that of the uncoated alloy. These results indicated the corrosion resistance was significantly improved by ZrN coating. In this paper, the Zr interlayer was designed to buffer the mismatch of the ZrN coating and the magnesium alloy, thus resulting in enhanced adhesion strength. However, this layer is also able to contribute to the corrosion resistance, Chou et al. [64] reported that bi-layer ZrN/Zr coating deposited on 304 stainless steel by a hollow cathode discharge ion plating (HCD-IP) system exhibited the highest corrosion resistance in comparison with single-layered Zr and ZrN coatings. The mechanism was explained as follows: the corrosion resistance of the specimen significantly dependent on the pinhole number and size [64], since the corrosion occurred via the diffusion of the electrolyte through pinholes and attacking the underneath metal substrates. The Zr layer was suggested to interrupt the pinhole connection through the coating surface to the underlying substrate, therefore reducing the exposure area of the substrate to the electrolyte.

Table 1. Summary of the anti-corrosion ZrN coatings.

**Table 1.** Summary of the anti-corrosion ZrN coatings.
Composition	Substrates	Methods	Electrolyte	Ref.
ZrN/Zr	biomedical AZ91 magnesium alloy	filtered cathodic arc deposition	simulated body fluids (SBF)	[60]
Zr, ZrN and ZrN/Zr	AISI 304 stainless steel	Hollow cathode discharge ion plating	0.5 M H₂SO₄ containing 0.05M KSCN	[64]
ZrN0.83/Zr	NiTi shape-memory alloy	plasma immersion ion implantation and deposition	Hank’s Solution	[75]
ZrN,TiN and Ti/TiN	316 L stainless steel	reactive magnetron sputtering	pH 5.6 acetic acid and sodium acetate buffer solution.	[62]
ZrN and ZrN-Ag nanocomposite	AISI 316 L surgical steel, and medical grade Ti-Al-V	reactive unbalanced magnetron sputtering	3.5% NaCl solution	[65]
TiN and ZrN	Plain carbon steel	an unbalanced magnetron sputtering technique/low or mild energetic ion bombardment with high flux	sulfuric acid solution (1N)	[66]

More interestingly, the incorporation of a certain amount of silver (Ag) in the ZrN coating enhanced the corrosion resistance of the coating whilst also introducing antibacterial properties to the coating. Kertzman et al. [65] reported that the nanocomposite films of ZrN-Ag fabricated using reactive unbalanced magnetron sputtering possessed a dense and homogenous microstructure wherein Ag nanocrystals were distributed evenly throughout the ZrN matrix. Its corrosion resistance was proved to be better than ZrN coating alone and dependent on the bias potential used during deposition. It was thought that Ag addition reduced the depth of the pits distributed in the coating, thus retarding the pitting corrosion. The effect of surface defects or morphologies on the corrosion resistance was investigated by Kelesoglu et al. [66]. They found that the improved corrosion resistance of the magnetron sputtered ZrN coating on plain carbon steels (Ck35) was parallel to the morphological improvement in the coatings (i.e., reduced porosity and surface defects). Low or mild energetic ion bombardment with high flux was proved to be an effective way to improve the morphology of the coating.

Titanium nitride (TiN) is another important ceramic coatings being studied for a biomedical application as it has good biocompatibility [67,68], anti-corrosion and anti-wear properties [62,66,69,70,71,72,73,74]. Table 2 shows a summary of TiN coatings for anti-corrosion. TiN coating on the femoral head of Ti-6Al-4V artificial hip joints was proved to significantly reduce the passive current density by approximately 2 orders of magnitude [71] indicating great improvement of the anti-corrosion property. However, due to some inherent shortcomings of some film deposition methods, or impropriety of the process parameters, surface defects like pinhole or macro pore, sometimes even micro cracks are often formed in the coating. In this case, although the corrosion rate can be somewhat reduced in the early stage, it deteriorates rapidly after the long-term immersion in electrolyte as pitting corrosion occurs in the pinhole [70].

Table 2. Summary of anti-corrosion TiN coatings.

**Table 2.** Summary of anti-corrosion TiN coatings.
Ref.	Substrate	Methods	Electrolyte
[62]	316-L stainless steel	reactive magnetron sputtering	pH 5.6 acetic acid and sodium acetate buffer solution
[66]	Plain carbon stee (Ck35)	unbalanced magnetron sputtering technique	1 N sulfuric acid solution
[69]	Biomedical NiTi shape memory alloy	plasma immersion ion implantation and deposition (PIIID)	Hank’s solution
[70]	1Cr11Ni2W2MoV Martensitic stainless steel	hollow cathode ionic plating (HCIP)	0.5 mol/L NaCl and 1mol/L H₂SO₄ diluted aqueous solution
[71]	Ti-6Al-4V	plasma assisted electron beam PVD technique	0.5 N NaCl solution
[73]	NiTi coated Si	dc magnetron sputtering	1 mol/L NaCl solution
[74]	Biomedical AISI 316L stainless steel	arc ion plating	neutral Troyde’s simulated body fluid

Just as the Zr interlayer can enhance the corrosion resistance of ZrN coating [64], the Ti interlayer can enhance that of TiN coating [74]. Additionally, Li et al. [70] demonstrated that introduction of certain amount of Al in the TiN coating improved the long-term performance of TiN coating because the corrosion process was obstructed by the corrosion product of Al on the interface between the coating and substrate. Other methods like ion beam mixing [62] and high-flux ion bombardment [66] can also improve the corrosion resistance of the TiN coating.

Fu et al. [76] deposited TiN layer on TiNi film by co-sputtering a Ti0.5Ni0.5 target on silicon substrate first and then sputtering Ti target in Ar/N₂ atmosphere. It was reported that TiN layer formed on the TiNi film significantly increased its hardness from 2.5 GPa to 9.3 GPa despite the fact that the TiN layer was only about 300nm. The scratching and sliding wear tests showed that the coefficient of friction, load bearing capacity and wear resistance of the TiNi films were effectively improved. Besides the methods mentioned above, other techniques such as ion implantation [77,78,79,80,81], PVD [71,82,83,84], plasma nitriding [85,86,87] and laser nitriding [88,89,90] can also fabricate nitride protective coatings or films on metal implants.

In summary, both ZrN and TiN films or coatings can successfully protect metal implants from corrosion. However, the anti-corrosion ability is strongly depending on the quality of the coating. Defects such as pinholes, pits and macro-pores in the coating are detrimental to its corrosion resistance. Besides, the interfacial adhesion between the coating and metal substrates also plays an important role. Therefore, optimum process parameters and proper post-treatments are required.

2.3. Diamond-like Carbon (DLC) Films

Diamond-like carbon (DLC) has a high wear and corrosion resistance, chemical inertness, high electrical resistivity, infrared-transparency, high refractive index and excellent smoothness. All these merits render it a good biomaterial for application in orthopedic, cardiovascular, contact lenses, or dentistry. Many surface modification techniques have been applied to produce DLC films with a variety of carbonaceous precursor materials, including ion beam deposition [91], plasma-assisted chemical vapor deposition (PACVD) [92], filtered cathodic vacuum arc (FCVA) [93], ion plating [94], plasma immersion ion implantation and deposition (PIIID) [95], magnetron sputtering [96], ion beam sputtering [97], pulsed laser deposition [98] and mass selected ion beam deposition [99,100]. Some excellent reviews on DLC films have been published in the past several decades [101,102,103,104,105,106]. Reviews written by Robertson [104], Bhushan [103], and Erdemir [101] described the deposition methods, deposition mechanisms, characterization methods, electronic structure, gap states, defects, doping, luminescence, field emission, mechanical properties and some application of DLC. Reviews written by Dearnaley [105], Grill [102] and Hauert [106] mainly focused on the biocompatibility and biomedical application of the DLC films. This section is attempting to sum up the major influencing factors on the tribological and corrosive properties of the DLC films.

The mechanical and tribological properties of a DLC film depend on the sp³/sp² ratio, the amount of hydrogen in the films, and adhesion of the film to the substrate. The type of deposition techniques, processing parameters like precursor materials, kinetic energy of the carbon species prior to deposition, deposition rate and even the substrates conditions greatly influence the mechanical and tribological properties of the DLC film [103].

A: sp³/sp² ratio: Two types of carbon-carbon interatomic bond exist in the diamond-like carbon (DLC) films, one is sp² hybridization, as in graphite; the other one is sp³ hybridization, as in diamond. The sp³/sp² ratio in different DLC films varies significantly depending on the type of the applied deposition techniques and the used procedure parameters. Usually, films with a high proportion of sp²-bonded carbon atoms tend to be relatively soft and behave more like graphite during tribological tests, while films with more sp³-bonded carbons are more like diamond, and hence they are superhard and provide impressive tribological properties. The review written by Bhushan states that sp³/sp² frictions are in the decreasing order for cathodic arc deposition, pulsed laser vaporization, direct ion beam deposition, plasma-enhanced chemical vapor deposition (PECVD), ion beam sputtering and DC/RF sputtering [103]. In this review paper, it was also proposed that the deposition of sp³-bonded carbon required the depositing species to have a kinetic energy in the order of 100ev or higher. Excess energy, such as that from substrate heating, is detrimental to the achievement of high sp³ friction.
B: Hydrogen content: DLC films sputtered with the addition of H₂ or derived from a hydrocarbon source, such as acetylene or methane possess a large amount of hydrogen in the films. It is interesting that there is still about 10% hydrogen present in the DLC films sputtered in 100% Ar by direct current (DC) magnetron sputtering [107]. Hydrogen causes the shift of C-C bonds from sp² to sp³, and generation of a larger number of C-H bonds which relieve the internal stress and produces a softer polymer-like materials. Compared with hydrogen-free DLC films, such films with a high degree of hydrogenation have low friction and wear especially when tests are performed in inert or vacuum test environments [101]. But in the moisture or water environments, their friction increases substantially as the condensed water molecules can give rise to capillary forces [101]. Ronkainen et al. [108] evaluated the tribological performance of different DLC films in water-lubricated conditions. Their results showed that the amorphous hydrogenated carbon films could not survive in the water-lubricated conditions, and was worn through during the test, while the hydrogen-free DLC films fabricated by vacuum arc discharge exhibited the best wear resistance. However, the wear resistance of hydrogenated DLC films can be improved by doping with Si, W and Cr or by interlayers [108].
C: Surface roughness: Surface roughness of the DLC films and its underlying substrates has a decisive influence on the wear of the counterface, especially in the case of a soft material such as ultra high molecular weight polyenthylene (UHMWPE). It was reported that even single scratches in the film, which may be undetectable by an average surface roughness measurement, are capable of increasing the wear rate of UHMWPE by a factor of 30–70 [109]. The effect of the substrate surface roughness on the wear behavior of DLC films was investigated on a ball-on-disk wear rig in dry air by Jiang et al. [110]. The wear rate of the films increased significantly with the increase in the substrate surface roughness, while the frictional behavior was not apparently affected. Roughness of 0.93 μm was found to be the critical substrate surface roughness, above which the dominant wear mechanism changed from adhesion to chip/flask formation and fragmentation [110].
D: Film thickness: Thick films are preferred for protecting metal from corrosion and wear. However, the compressive stress limits the maximum thickness of the adhesive films and may cause delamination during wearing. Therefore, various methods are used to improve the adhesion strength and reduce the compressive stress. Firstly, cleaning the surface of the substrates with Ar ion bombardment before film deposition is good for the availability of high interfacial adhesion strength. Secondly, forming a mixed interface between film and substrate in the first stage of deposition can also increase the adhesion strength. Thirdly, doping with metal or non-metal elements to reduce the internal stress of the film is also an effective way to obtain high adhesion strength. It was reported that Si doping could improve adhesion strength and reduce internal stress [111], thus increasing the thermal stability of the film as well as the insensitivity of the coefficient of friction to the humidity [112]. Doping metals such as Ta, W, Ti, Nb and Zr in the hydrogenated DLC film also decreased internal stress and lower the dependence of the friction coefficient of the film on humidity [113]. Fourthly, a multilayer approach using alternate soft layer is another effective way to reduce compressive stress in DLC film. Film fabricated by this method showed good friction and wear performance [114]. Finally, diamond-like nanocomposite (DLN) film. DLN film is a new class of materials with reduced compressive stress and increased adhesion strength. This kind of film is composed of two interpenetrating amorphous random network, one is a DLC (α-C:H) network and the other is a glass-like α-Si:O network [113]. Its advantages also include higher temperature stability and a low coefficient of friction.

Although many good results have been obtained on the wear performance of DLC films, some contradictory results are also reported by researchers. In the review of [115], Roy et al. gave two examples. Firstly, clinical tests of DLC-coated vascular stents revealed that the DLC film did not provide significant improvements in restenosis rate over uncoated stents. Secondly, ten-year follow-up of DLC-coated artificial hip joints showed that failure rate of the DLC-coated Ti-6Al-4V femoral head was much higher than alumina femoral head. These controversies should be further discussed and more In vitro and In vitro studies should be done before clinically used on biomedical devices.

3. Biocompatibility and Bioactivity

Biomedical implant materials are expected to be biocompatible, bioactive, non-toxic and should not cause any inflammatory or allergic reaction. Biocompatibility was defined as the “acceptance of an artificial implant by the surrounding tissues and by the body as a whole” [116]. For some specialized biomaterials, biocompatibility also includes adequate mechanical properties, appropriate optical properties and suitable density [116].

According to the European Society for Biomaterials consensus conference of 1987, a bioactive material is “one which has been designed to induce specific biological activity”. Upon implantation in human body, bioactive materials are capable of inducing the formation of bony tissue around the implant material and strongly integrating with the implant surface, which is called osseointergration. For bone-bonding materials, bioactive materials are those can induce bone-like HA formation both in vitro and in vivo [117,118]. Since this review is dealing with the biomedical coatings for hard-tissue application, the term of bioactivity present in the review represents their bone formation ability.

Both biocompatibility and bioactivity of a biomaterial are strongly dependent on its surface properties because cascades of biological reactions occur firstly and directly on its surface as soon as it is fixed into a body [119]. Thereafter, surface properties of an implant, such as surface topography, surface chemical and physical properties as well as surface roughness, will influence the performance of the implant. Recent progresses on coatings for improving the biocompatibility and bioactivity of metallic implants are reviewed below.

Calcium phosphates are the most important inorganic constituent of biological hard tissues. Comprehensive overviews of the basic science and significance of calcium phosphate as biomaterials were given by Paital [120], Dorozhkin [121] and Bohner [122]. Table 3 derived from [121] lists properties of the biologically relevant calcium orthophosphates. So far, only two compounds (i.e., hydroxyapatite (Ca₁₀(PO)₆(OH)₂) and tricalcium phosphate (α or β-Ca₃(PO₄)₂)) have been extensively tested both In vitro and in vivo [123]. HA is biocompatible and bioactive in the human body due to its similarity to the mineral component of natural bone. It can adhere directly to osseous, soft, and muscular tissue without an intermediate layer of modified tissue. Various surface modification methods have been applied to fabricate Ca-P coatings, including dip and immersion coating [124], electrophoretic deposition [125], hot isostatic pressing [126], laser deposition [127], thermal spraying (including plasma spraying [128], high-velocity oxy-fuel combustion spraying [129], solution deposition [130], biomimetic coating [131,132] and sol-gel coating [133,134]. Detailed descriptions and comparisons of these methods can be found in the review articles [123,135]. Table 4 lists some characteristics of those often-used surface techniques. Amongst these surface techniques, plasma spraying is currently the most favorable method commercially available for coating biomedical implant devices with HA. Plasma sprayed HA coatings and those influencing factors in their biocompatibility and bioactivity are discussed as follows.

3.1. Hydroxyapatite (HA) Coatings

Table 3. Properties of the biologically relevant calcium orthophosphate. (Reproduced with permission from Prof. Epple, M. [121])

**Table 3.** Properties of the biologically relevant calcium orthophosphate. (Reproduced with permission from Prof. Epple, M. [121])
Ca/P ratio	Compound	Formula	Solubility at 25^oC, –log(K_sp)	Solubility at 37 ^oC, –log(K_sp)	pH stability range in aqueous solution at 25 ^oC
0.5	monocalcium phosphate monohydrate (MCPM)	Ca(H₂PO₄)₂·H₂O	1.14	no data	0.0–2.0
0.5	monocalcium phosphate anhydrate	Ca(H₂PO₄)₂	1.14	no data	[d]
1.0	diacalcium phosphate dehydrate (DCPD, “brushite”)	CaHPO₄·2H₂O	6.59	6.63	2.0–6.0
1.0	diacalcium phosphate anhydrate (DCPA, “monetite”)	CaHPO₄	6.90	7.02	[d]
1.33	octacalcium phosphate (OCP)	Ca₈(HPO₄)₂(PO₄)₄·5H₂O	96.6	95.9	5.5–7.0
1.5	α-tricalcium phosphate (α-TCP)	α-Ca₃(PO4)₂	25.5	25.5	[b]
1.5	β-tricalcium phosphate (β -TCP)	β-Ca₃(PO₄)₂	28.9	29.5	[b]
1.2-2.2	amorphous calcium phosphate (ACP)	Ca_x(PO₄)_y·nH₂O	[c]	[c]	[c]
1.5–1.67	Calcium-deficient hydroxyapatite (CDHA)	Ca_10-x(HPO₄)_x(PO₄)_6-x(OH)_2-x (0 < x < 1)	≈ 85.1	≈ 85.1	≈ 6.5–9.5
1.67	hydroxyapatite	Ca₁₀(PO₄)₆(OH)₂	116.8	117.2	9.5–12
2.0	tetracalcium phosphate (TTCP)	Ca₄(PO₄)₂O	38–44	37–42	[b]

The solubility is given as the logarithm of the ion product of the given formulae (excluding hydrate water) with concentrations in mol/L. [b] these compounds cannot be precipitated from aqueous solution). [c] cannot be measured precisely. However, the following values were reported: 25.7 ± 0.1 (pH 7.40), 29.9 ± 0.1 (pH 6.00), 32.7 ± 0.1 (pH 5.28). [d] Stable at temperatures above 100 °C. [e] Always metastable. The composition of a precipitate depends on the solution pH values and composition [121].

Plasma sprayed HA coating was first used for improving the fixation between bone and implants in 1980s [136] and the clinical trials of HA coatings first used in the femoral stem was by Furlong et al. in 1985 and was reported in 1991 [137]. Since then, HA coatings have been extensively studied and their applications have extended to coat acetabular components, knee prosthesis, pin/screw components and dental implants [128]. The quality of HA coatings is strongly depend on their fabrication methods and can be characterized by the following specifications: crystallinity, thickness, phase composition, surface roughness, microstructure and porosity, among which microstructure, crystallinity, surface roughness and phase composition are of great importance to their biocompatibility and bioactivity.

Table 4. Summary of surface techniques for depositing Ca & P coatings on metal implants and their characteristics.

**Table 4.** Summary of surface techniques for depositing Ca & P coatings on metal implants and their characteristics.
Methods	Characteristics
Dip and immersion coating	High temperature for post-sintering HA layer can degrade the strength of the metal and impair the interfacial adhesion and cause the decomposition of HA
Electrophoresis deposition	Low bond strength and non-uniform thickness of the coating
Hot isostatic pressing	Difficult to seal borders on implants with complex shapes, high temperature during the process may denature HA
Solution deposition	A low temperature deposition method resulting in a pure, highly crystalline, firmly adherent coating
Sputtering deposition	A line-of-sight technique with low deposition rate and high cost, but the coatings are dense and with uniform thickness on flat substrates
Thermal spraying	A line-of-sight technique with high deposition rates and low cost; high temperature may cause decomposition of HA; high cooling rate may result in the formation of nanostructure, coatings usually have micro-rough surface
Sol-gel	Not a line-of-sight technique suitable for coating substrates with complex shapes; processing temperature is low; raw materials are expansive and sometimes including organic toxic solvent.
Biomimetic coating	Low processing temperature technique capable of coating complex-shaped substrates; time-consuming
Laser deposition	Be capable to restore complex stoichiometries and to produce crystalline and highly adherent coatings, but process temperature may cause the oxidation of metal or alloy substrates.

A: Crytallinility: Crystallinity of plasma sprayed HA coating varies from 50% to 90%. Currently, there is no agreement on what the optimum crystallinity should be. However, it is generally agreed that HA coatings with low crystallinity have higher tendency to dissolve in the body fluid thus giving rise to a faster bone growth rate compared to those with high crystallinity. However, high dissolution rate of the HA coating may lead to mechanical degradation, deterioration of the interfacial adhesion, which would finally lead to the loss of the fixation and delamination of the coating. In addition, the debris from the coating may cause undesired inflammatory reaction, thereby compromising the fixation of the implant to bone [3].
B: Phase composition: High temperature process of plasma spraying usually causes the decomposition of certain amount of HA phase into an amorphous and tricalcium phosphate (α and/or β-TCP), tetracalcium phosphate (Ca₄P₂O₉; i.e., TTCP) and calcium oxide (CaO). The dissolution rates of these decomposition products are much higher than that of HA, and are in the order of TTCP >> α-TCP > β-TCP >> HA [128]. The fast dissolution of these Ca & P compounds can easily produce supersaturated environment for precipitation of apatite on the coating surface, leading to an enhanced bone growth. It should be stressed that calcium oxide is not biocompatible and should be avoided although it has a high dissolution rate [128]. The side effect of the decomposition of HA is that the fast dissolution of the newly formed Ca & P compound may cause the undesirable fast degradation of the coating. Therefore, both the cystallinity and phase composition should be well designed or controlled for the biomedical use of HA coatings.
C: Microstructure and porosity: Microstructure and porosity of the HA coatings, depending on the process parameters, particle size and size distribution of the feedstock powders, can control the specific surface area of the coating thus influencing the physiochemical interactions at the implant-host interface [138].
D: Surface roughness: Surface roughness of the HA coating has a significant effect both on the initial mechanical stability of fixation and on osteo-integration. Plasma sprayed HA coating has a roughness of several micrometers, which is strongly influenced by the spray parameters [138], such as spray distance, spraying current, plasma forming gases, and powders conditions. Evidence suggests that rougher surface exhibits a greater mechanical fixation with the nature bone as they are more capable to enhance the adhesion of osteoblast cells and their subsequent proliferation and differentiation [139,140]. The proposed mechanism was that rough surface could induce the release of growth factors and cytokines in the adhering osteoblasts [141]. Additionally, rough surface also favors the precipitation of apatite. Firstly, high roughness allows a large contact area between the coating surface and the body fluid, resulting in an increased Ca & P release. Secondly, rough surface provides more nucleation sides with lower interface energy for bone-like apatite to anchor [142].

A major concern of the plasma sprayed HA coating is its low bonding strength to metal or alloy substrates due to the mismatch of thermal expansion coefficients between HA (13.3 × 10^-6 K^-1) and substrates (Titanium: 8.4-8.8 × 10^-6 K^-1; Co-Cr alloy: 16 × 10^-6 K^-1). Interlayer like Ti can somewhat reduce the mismatch of thermal expansion coefficients between HA and substrates thus increasing their bonding strength [143]. In addition, HA coatings are generally brittle with low fracture toughness. Evidence showed that HA composites with TiO₂ [144,145], Al₂O₃ [146,147] and ZrO₂ [148,149] can overcome this mechanical shortcoming to a certain extent. Recently, it was reported that the introduction of nano carbon tubes could improve the mechanical properties of HA coating [150,151,152,153] without undermining its biocompatibility [152].

Besides plasma spraying, some thin film techniques have also been used to deposit calcium phosphate films. Pulsed laser deposition (PLD) is recently extended to produce calcium phosphate coatings on biomedical substrates. PLD has some advantages over other physical surface modification methods, such as the stoichiometry of the target can be retained in the deposition films; multilayered film can be deposited with a laser beam by simply changing target materials using a rotational multi-target holder; lower temperature is needed to deposit the films; the crystallinity can be well controlled [153].

A typical PLD process is as follows: a pulsed laser beam is focused onto the surface of the rotating target situated inside a vacuum chamber; with the laser radiation interaction, the target material is dissociated and ablated out; the ablated species are deposited onto the substrates surfaces [153,154]. Compared to plasma spraying technique, PLD is able to deposit films with similar chemical composition to the target material due to the flash vaporization resulted from the rapidly transferred energy from the laser beam, which makes PLD a promising technique for coating HA onto metal substrates.

Just like plasma sprayed HA coatings, the bioactivity and biocompatibility of HA films deposited by PLD, are strongly dependant on the crystallinity and chemical composition of the coated material. Gas environment and substrate temperature are the two main influencing factors on the crystallinity and on the Ca/P ratio of HA films deposited by PLD techniques. It was reported that if the temperature of the substrate is below 400 °C, amorphous HA films will be produced [155]. Increasing substrate temperatures is beneficial for producing HA coating with a high crystallinity. However, high temperatures may result in the formation of non-stoichiometries HA films [156,157], which was ascribed to the re-evaporation of phosphorus during the deposition process [158]. Gaseous environment also plays an important role on the formation of crystallized HA films. In an inert gaseous environment, amorphous HA films were produced at substrate temperatures between 400 °C and 600 °C. With the presence of water vapor in the gaseous environment, crystalline HA films were formed [154]. However, the pressure of the water vapor should be accurately controlled. Fernández-Pradas et al. [159] found that the water vapor pressure should be near 0.5 mbar in order to get a highly crystalline HA films for both 193 nm and 248 nm excimer laser wavelengths. The water vapor pressure also has great influence on the Ca/P ratio of the HA films. With KrF excimer wavelength and laser energy density of 3.53 J cm^-2, TTCP (Ca/P = 2) was found in the HA films if the water vapor pressure was below 50 Pa, while α-TCP was formed when the pressure was above 50 Pa. Laser energy density can affect the crystallinity of the HA films [160,161]. It was reported that HA films fabricated at a laser energy density of 3 J cm^-2 exhibited 98% crystallinity after annealed at 400 °C, while those at a laser energy density of 9 J cm^-2 possessed only 87% crystallinity after subjected to the same annealing process. Besides gaseous environment, substrate temperature, laser energy density and water vapour pressure, the quality of the PLD HA films is also influenced by laser wavelengths [162] and pulse repetition rate [163,164].

The main drawback of HA films fabricated by PLD is the splashing or the particulates deposition on the film which may roughen the film surface. Studies showed that particulate deposition can be reduced or avoided by using short wavelength laser [165], or a mechanical particle filter which can remove slow-moving particulate [154], or by using a sintered HA target with a high density and a defect-free smooth surface [154].

Ion beam techniques, such as ion beam sputtering deposition (IBSD) [166,167,168,169], ion beam assisted deposition (IBAD) (Figure 2) [168,170,171] have also been widely used to deposit calcium phosphate thin films on the metallic substrates. These techniques can produce a thin, homogeneous calcium phosphate with high adhesive strength. In IBSD process (Figure 2a), metal substrates are first fixed on a rotating stage located in the vacuum chamber. After a minimum base pressure is obtained, high purity argon is backfilled the chamber to a pressure with which the deposition is accomplished. Then, substrates precleaned by Ar-sputtering are coated with ions sputtered from the targets. Ong et al. [172] deposited thin amorphous HA films on titanium substrates with HA-fluorapatite sintered target. The bonding strength of the as-sputtered films is 38.0 ± 8.2 MPa.

Figure 2b shows the typical process of IBAD. The differences between the IBSD and IBAD are that the latter is combined with ion beam bombardment. The most important advantage of IBAD over IBSD is that a higher adhesive strength can be obtained because an atomic intermixed interface is formed by the ion bombardment [168,170,173]. Hamdi et al. [170] prepared HA films by using ion beam deposition assisted by an Ar ion beam with preheated CaO and P₂O₅ powder as Ca and P precursors. It was proved that the Ca/P ratio of the films strongly depended on the ion beam current density, indicating that the chemical composition is controllable by changing the processing parameters. Cui et al. [168] compared the adhesive strength of the HA films deposited by IBSD and IBAD techniques. The target they used was composed of 70% HA and 30% tricalcium phosphate (Ca₃(PO₄)₂, TCP). The bombardment energy of Ar⁺ beam used to produce an atomic intermixed interface between film and substrate was 30keV, while that for assisting coating growth and reinforcing coating compactness was 200eV. The adhesive strength of IBAD coating was nearly twice that of IBSD coating. Using energetic Ca²⁺ ion beam, HA films with high adhesive strength can also be obtained [172,174,175,176]. Besides high adhesive strength, low substrate temperature, high reproducibility, and controllability over microstructure and chemical composition also make IBAD attractive for coating metallic substrates with HA [170].

The main drawback of the HA films fabricated by ion beam techniques is their amorphous phase composition which leads to high dissolution rate in biological fluids [167,177]. To increase the crystallinity of HA films, heat treatments at 500 °C–600 °C are often utilized [166,172]. However, heat-treatment has some negative effects on the adhesive strength of HA to metallic substrates. Even so, the adhesive strength of HA films deposited by ion beam technique is higher than those fabricated by using plasma spraying [176].

Figure 2. Schematic maps of typical IBSD and IBAD process (a) IBSD. (b) IBAD.

Magnetron sputtering deposition is anther effective way to produce HA films on biomedical implants. The process is similar to that of ion beam sputtering deposition. Briefly, when powder is supplied to a magnetron, a negative voltage is applied to the target. With this negative voltage, positive ions can be attracted to the target surface, leading to the collision with the target surface at the atomic level. Then, atoms sputtered from the target conform to the substrate surface and form a film. Distinctly, a magnetron field is used in the magnetron sputtering process in order to confine the secondary electron close to the target, thus increasing the collision rate of sputtering ions with the atoms of the targets [178,179]. To enhance the adhesive strength of magnetron-sputtered HA films with metallic substrates, composite HA coating with Ti [180] and functionally graded HA/Ti films [178] have been fabricated. In addition, using TiN interlayers between the HA films and substrates can also increase the adhesive strength [181]. For improving the cytocompatibility of the HA films, bioactive elements like Si are introduced to HA films with magnetron co-sputtering deposition technique [182]. Other thin film techniques, such as hot isostatic pressing [126,183], biomimetic methods [131,132,184,185], and sol-gel method [133,134,186,187] can also be utilized to deposit HA films on metallic substrates.

3.2. Bioactive Glass and Glass-ceramics Coatings

Besides those mentioned above, another important branch in bioactive coating family is CaO-SiO₂ based materials, namely bioglass, bioceramic, and glass-ceramic. Since Hench discovered bioglass in 1969 [188], these CaO-SiO₂ based materials have been extensively studied. Their excellent bioactivity and well-documented biocompatibility make them ideal for biomedical applications, particularly in orthopaedic and dental implants.

Bioactive glasses and glass-ceramics can indeed elicit complex, multi-stage interactions with living body fluids and living tissues, whereby the surface of the component undergoes chemical and structural alterations which subsequently favour the growth of bone tissues [117]. The glassy network of these materials can be partially dissolved by body fluids, releasing Ca²⁺ and P⁵⁺ ions and forming large amounts of bioactive Si-OH groups. Si-OH groups on the coating surface are beneficial for the nucleation and growth of apatite in the body fluids which is supersaturated with respect to HA [189], thus leading to the formation of a surface layer with a chemical and structural affinity to bone tissues. Si ions released from bioglass can stimulate intracellular reactions and further assist the bone tissue in bonding to the surface of bioglass [190,191,192].

Surface techniques for producing bioglass coatings include plasma spraying [193], high-velocity suspension flame spraying [190], sol-gel [192,194], enameling technique [195], electrophoretic deposition [196], ion beam sputtering [197], laser cladding [198], and pulsed laser deposition [199]. Plasma spraying and sol-gel coating techniques are used more frequently. Interfacial bonding is a main concern involved in the plasma sprayed bioglass coating due to the mismatch of thermal expansion coefficients between the glass and the underlying metallic substrates. Compositing with HA [200], and properly adjusting SiO₂ amount [201] can improve the bonding strength of bioactive glass to the metallic implants. Sol-gel is an alternative method for coating bioglass on metallic implants by which bioglass coating is fabricated at much lower temperatures than those traditional methods require. Sol-gel derived bioglass has a number of advantages over melt-derived glass, including purity, homogeneity, higher rate of hydroxyl-carbonate apatite (HCA) layer formation and resultantly rapid bone fixation [192]. Additionally, the bioactive range in the CaO-SiO₂-P₂O₅ is larger for sol-gel materials than that for the corresponding glass obtained by melting [202].

Recently, CaO-SiO₂ based bioceramic coatings, such as wollastonite (CaSiO₃), dicalcium silicate (Ca₂SiO₄) and diposide (CaMgSi₂O₆), have been widely studied by Liu and Xue et al. [203]. Figure 3 displays the surface morphologies of plasma sprayed CaO-SiO₂ based bioceramic coatings after immersion in SBF solution. Bone-like HA is formed on the surface of plasma sprayed CaSiO₃ coatings after immersion in SBF solution for 1 day (Figure 3a) [204,205]. For plasma sprayed Ca₂SiO₄ coating, some apatite particles were observed on the coating surface only after 1 hour and a dense apatite layer was formed after 1 day (Figure 3b), indicating the superior bioactivity of plasma sprayed Ca₂SiO₄ coatings [206]. For plasma sprayed CaMgSi₂O₆ coating, 5 days are needed to induce the formation of apatite [207,208], as shown in Figure 3c. The main mechanisms for the bioactivity of the plasma sprayed CaO-SiO₂ based ceramic coatings can be depicted as follows [209]: Ca ions are firstly dissolved from coatings leading to increased ion activity product of the apatite in the surrounding body fluid. As a result, a Si-rich layer with a large amount of negatively charged Si-OH groups is formed, which is favorable for apatite nucleation and growth. The dissolution rates of these three coatings are in the following ascending order: Ca₂SiO₄ > CaSiO₃ > CaMgSi₂O₆. However, the high dissolution rates of these coatings, especially for Ca₂SiO₄ and CaSiO₃, are harmful to their long-term and mechanical stability. However, compositing CaSiO₃ and Ca₂SiO₄ coatings with certain amount of TiO₂ and ZrO₂ can improve their mechanical properties without impairing their bioactivity [210,211]. In vitro cell experiments showed that osteoblast cells can adhere, proliferate and grow well on these coatings indicating that plasma sprayed CaO-SiO₂ based ceramic coatings are cytocompatible [206,207,208]. Moreover, Sun et al. [212] found that the dissolution products from plasma sprayed Ca₂SiO₄ coatings could enhance the expression of osteoblast-related genes and promote differentiation of MG63 cells at the initial period in agreement with the cell responses to bioactive glass, as mentioned above. Additionally, incorporation of biologically relevant trace elements such as zinc [213], strontium [214] and zirconia [215] can enhance the bioactivity and cytocompatibility of Ca-Si based biomaterials [213,214,215].

Figure 3. Comparison of bone-like apatite formation on plasma sprayed CaO-SiO₂ based bioceramic coatings after immersion in SBF solution: (a) CaSiO₃ coating immersed in SBF solution for 1 day. (b). Ca₂SiO₄ coating immersed in SBF solution for 1 day. (c) CaMgSi₂O₆ coating immersed in SBF solution for 5 days. (Figure 3a and b are reprinted with the permission from Liu, X.Y. [204,205]; Figure 3c is reprinted with the permission from Xue, W.C. [207])

3.3 Bioactive Oxide Coatings

Oxide coatings, such as TiO₂ [216,217,218], ZrO₂ [219,220,221] and SiO₂ [222] also have bioactivity. However, their bioactivity is depending on the coating techniques and the process parameters. A summary of bioactive oxide coatings is given in Table 5. Surface structure (including roughness, nano-sized grains), crystal structure, and surface –OH groups strongly influence the bioactivity of the oxide coatings. –OH groups result in negatively charged surfaces which account for the bioactivity of many sol-gel TiO₂ and SiO₂ coatings. However, the function of –OH groups varies according to the crystal structure where the –OH groups are located. For example, it has been proved that the –OH groups on anatase and rutile TiO₂ is more efficient in inducing apatite precipitation in SBF solution than amorphous TiO₂ [223]. Additionally, sol-gel alumina coatings do not show bioactivity although they have many –OH groups on their surfaces [222]. It is generally thought that zirconia is a bioinert material because zirconia ceramics scarcely possess the ability to induce bone formation in biological environment. However, recent studies by Wang et al. [219,224] and Han et al. [225,226,227] demonstrated the In vitro bioactivity of the plasma sprayed and micro-arc oxidized zirconia coatings. We previously showed that apatite precipitation on plasma sprayed zirconia coatings was influenced by the amount of dopant (calcia) used to stabilize zirconia. Figure 4 depicts the surface morphologies of the zirconia coating after 28 days of immersion in SBF solution. The undoped zirconia coating exhibited the best bioactivity with a dense, thick and uniform apatite layer formed on its surface, as Figure 4a and its inset show. The bioactivity of zirconia coating stabilized with 12.8 mol % calcia was a little bit weaker, which was reflected in the non-uniform thickness of the apatite layer on its surface, as the inset in Figure 4b shows. As calcia content increased to 16 mol % and 30 mol %, the amount of the newly-formed apatite particles apparently reduced (Figure 4c, d) indicating that their bioactivity becomes worse. These discrepancies in bioactivity were ascribed to their differences in surface micro- and nano-structure and in the phase composition [219,224].

Figure 4. Comparison of bone-like apatite formation on plasma sprayed zirconia coatings after immersed in SBF solution for 28 days. (a) undoped zirconia coating. (b) zirconia coating stabilized 12.8 mol % calcia. (c) zirconia coating stabilized with 16 mol % calcia. (d) zirconia coating stabilized with 30 mol % calcia.

Table 5. Summary of bioactive oxide coatings.

**Table 5.** Summary of bioactive oxide coatings.
Coating	Coating method	Ref.	Post-treatments	Phase	Influencing factors in bioactivity
TiO₂	Solution precursor plasma spray process	[234]	Chemically treated in 5M NaOH solution at 80 °C	Rutile	Formation of Ti-OH groups
	Sol-gel	[235]	none	Anatase	Surface topography; charge; charge density
		[222]	450 °C, 2 h	Anatase	Abundant Ti-OH groups and negatively charged surfaces
		[223]	Heat-treatment	Anatase	Crystal structure: anatase show more ability to induce apatite formation in SBF than rutile
	Plasma spraying & plasma immersion ion implantation (PIII)	[236]	Hydrogen incorporation by PIII	Rutile (bulk) & anatase (surface)	Combination of nanostructure and hydrogen incorporation can endow the coating with bioactivity
	Cathodic electrolytic deposition	[237]	None	Anatase (subcrystalline)	Crystal structure
			Below 300 °C	Anatase
			Above 500 °C	Rutile
	Anodic oxidation	[238]	H₂SO₄ and Na₂SO₄ solutions	rutile or rutile/anatase	Crystal structure: amorphous titania cannot induce apatite formation in SBF solution
	Anodic oxidation	[238]	CH₃COOH and H₃PO₄ solutions	amorphous titania
ZrO₂	Plasma spraying	[219,224]	None	Tetragonal (CaO-ZrO₂)	Nanostructured surface; crystal structure
	Plasma spraying	[219,224]	None	Monoclinic (undoped ZrO₂)	Nanostructured surface; crystal structure
	Cathodic arc deposition	[239]	None	Tetragonal (undoped ZrO₂)	Nanostructured surface
	Micro-arc oxidation	[225,227]	None	Monoclinic and small amount of tetragonal ZrO₂	Basic Zr-OH group
		[225,227]	NaOH treatment	Monoclinic and small amount of tetragonal ZrO₂
		[226]	Ultraviolet (UV) irradiation	Monoclinic and small amount of tetragonal ZrO₂
SiO₂	Sol-gel	[222]	Heat-treatment at 400 °C for 2 h	amorphous silica	Silanol group (Si-OH)

Ultraviolet irradiation is an effective post-treatment method to enhance the bioactivity of TiO₂ and ZrO₂ coatings. Its effects on plasma sprayed nanostructured TiO₂ coating and micro-arc oxidized ZrO₂ coatings were proved in two separate studies [226,228]. The enhanced bioactivity is due to the abundant Ti-OH or Zr-OH groups generated by photocatalysis effect of n-type semiconductor TiO₂ or ZrO₂ exposed to UV irradiation.

3.4. Bioactive Composite Coatings with Polymers

HA and Ca-Si based bioglass or bioceramic coatings possess excellent bioactivity and biocompatibility, however, their shortcomings in mechanical properties including brittleness, poor tensile strength and impact resistance, are limiting their uses in many load-bearing applications. Moreover, their surface characteristics arising from surface chemical composition may be not good enough for inducing selective cell adhesion, spreading, proliferation and differentiation. Inspired from the structure of nature bone, biopolymers such as collagen, gelatin, silk fibroin and poly(lactide-co-glycolide), have been used to composite with bioactive inorganic materials such as HA. The resultant composites are mechanically superior to individual component due to the ductile properties of the biopolymer which increase the fracture toughness of the inorganic component [229,230,231,232]. In addition, the composites have superior biological properties compared to the individual constituents as the composites combine their excellent bioactivity and biocompatibility [229,232].

3.5. Biological Molecules Incorporated Bioactive Coatings

Besides the surface modification methods mentioned above, the bioactivity, osteoconductivity or osseointegration can also be conferred on metal implants by incorporation of biological molecules, such as extracellular matrix, adhesion factors, growth factors and differentiation factors. This attempt or idea is based on the knowledge that adsorption of biomolecules onto the implant surface is a key process for cell adhesion and growth on biomaterials and plays a significant role on bone healing [119]. Therefore, immobilization of bioactive growth factors on the surface of the orthopaedic and dental implants are capable of inducing rapids cell functions, including cellular proliferation and differentiation activity, thus accelerating the tissue regeneration. As far as adhesion factors, fibronectin, various laminins and artificial peptides with specific cell signaling sequence like the RGD-sequence are widely investigated. Growth factors and differentiation factors like transforming factor β1 (TGF-β1), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF) and bone morphogenetic proteins (BMPs) are also intensively studied on their osteoinductive functions.

Some concerns regarding the immobilization of bioactive molecules on implants [240]. For example, a misbalance of growth factors has undesirable effects with several adverse side effects; high local doses can be associated with unresolved inflammation. Therefore, it is necessary to appropriately tailor the surface to have a controlled and local release of growth factors. The releasing rate is depending on the surface area of the implants, immobilization methods [241] and the type of carriers used [240].

Generally, the bioactive molecules are immobilized to metal implant surface by adsorption, covalent binding and incorporation in carriers [241]. Table 6 summarizes the different immobilization methods of bioactive molecules. The adsorption can be divided into physisorption and chemisorption, the latter is based on the chemisorptive interaction between the molecules and implant surface. Chemisorption is a useful way to tether/immobilize bioactive molecules to titanium implant surface, the interaction between phosphonate groups and surface oxides are thought to be the main mechanism [242]. Physisorption is based on the electrostatic interactions between the charged surface and the opposite-charged bioactive molecules. The nature of surface charge of an implant can be characterized by the isoelectric point (IEP). If the IEP of a surface is less than the pH value of peri-implant microenvironment, the surface will be negatively charged. In this case, positively charged biomolecules can be adsorbed to this surface. Conversely, the surface will be positively charged and ready for adsorption of negatively charged biomolecules. While the adsorptive method is simple, however, the fixation stability of the biomolecules is not sufficient and their release cannot be controlled [241].

Covalent coupling of bioactive molecules on biomaterial surfaces is an alternative method to adsorption immobilization, which allows a stable fixation of the bioactive molecules. Moreover, the biological activity of the bioactive molecules can be preserved if they are combined with some linker or spacers [243]. For covalent immobilization molecules onto the surface of metal implants, some functional groups should be introduced to their surface prior to covalent immobilization, or by coupling the bioactive molecules with some carriers such as collagen matrices, poly-L-lactide. For immobilization bimolecular on the surface of Ti implants, silanization is often performed before immobilization, to produce a surface with high affinity for some bioactive molecules. Naci et al. [244] linked aminoalkylsilane spacer molecules to the surface oxide of Ti implants by heating them in refluxing toluene containing 10% (3-aminopropyl)triethoxysilane, then covalently immobilized alkaline phosphatase or albumin. Results showed that bound proteins were at a biological relevant density and retained their enzymatic activity (alkaline phosphatase) and their antigenicity (albumin) [244]. Tebbe et al. [243] applied a similar method to covalently immobilize heparin to Ti substrates and studied the effects of the spacer length on the heparin coupling efficiency and fibrinogen adsorption. They revealed that the long chain of the spacer molecule was beneficial for the covalent attachment of heparin and samples with long chain spacer molecules showed better biocompatibility.

Besides chemical modification, plasma-based surface modification techniques are also effective and economical to create surfaces suitable for covalent immobilization of bioactive molecules. Comprehensive reviews on plasma-based surface modification of biomaterials have been done by other researchers [32,245]. The review written by Siow et al. [245] specially focused on plasmas that generate surfaces with chemically reactive groups by which covalent immobilization of bioactive molecules can be realized. For detailed information, the reader needs to refer to these two review papers [32,245].

With the use of plasma techniques, functional groups like carboxyl, hydroxyl, amine and aldehyde can be introduced to the surfaces of biomaterials. Surfaces containing these groups have biocompatibility and well-established chemical reactions for grafting bioactive molecules such as enzymes, antibodies, proteins, and glysosaminoglycans [245]. Usually, these functional groups can be introduced to surfaces of biomaterials by two ways: plasma treatment in proper gases (e.g., O₂, N₂, NH₃ and CF₄) and plasma polymerization of monomers containing the desired groups. Take amine groups for example, they can be formed on the metal surfaces by both plasma treatment with ammonia [246,247] and plasma polymerization of alkylamine [248,249]. Puleo et al. [250] successfully immobilized bioactive bone morphogenetic protein-4 (BMP-4) on titanium alloy using plasma polymerization of allyl amine. After the plasma polymerization, two-step scheme was used to immobilize protein. Briefly, before immobilization of protein, the amino groups were firstly converted to carboxyl groups by immersion aminated samples in 4% succinic anhydride at room temperature overnight, and then samples were treated with a solution of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC) and N-hydroxysuccinimide (NHS) in a 2-(N-morpholino)ethanesulfonic (MES) buffer. Results showed that the two-step carbodiimide immobilization scheme could retain the activity of BMP-4 [250].

For some applications, a sustained release of bioactive molecules over a long time is required. To achieve this goal, researchers are attempting to incorporate the bioactive molecules into organic coatings such as collagen [258], poly(D,L-lactide) (PDLLA) [257], poly(lactide-co-glycolide) (PLGA) [259] and ethylene vinyl acetate (EVAc) [260]. Schmidmaier et al. [257] used BMP-2 to modify the Titanium Kirschner wires with Poly (d,l-lactide) as a carrier, aiming at tailoring the implant surface to have a controlled, local release of growth factors. X-rays demonstrated an almost completely consolidated fracture, biomechanical testing showed a significantly higher maximum load and torsional stiffness, and histological and histomorphometric analyses demonstrated progressed remodeling for samples with IGF-1 and TGF-β1, compared to those without IGF-1 and TGF-β1.

In summary, both chemical modification and plasma-based modification can be used to immobilize bioactive molecules onto the surface orthopaedic and dental implant. Although plasma treatment and plasma polymerization are very useful for immobilization of bioactive molecules onto biomaterial surface, the substrates used are mainly composed of polymers. Studies on the metal substrates for orthopaedic application are less comprehensive. This section mainly focuses on the modification of metal or alloys for orthopaedic and dental application, more information on biomolecule-based surface modification can be found in reviews [119,241,261,262].

4. Antibacterial Coatings

Bacterial infection at the site of implanted medical devices is a serious ongoing problem in the biomedical filed. It was reported that approximately 11200 (4.3%) of orthopaedic implants are infected among the 2.6 million inserted into human body annually in United States [263]. Bacterial infection not only causes serious pains and sufferings to patients but also increases the medical cost. In serious cases, prosthesis has to be removed and revision surgery is required. However, the success probability of revision surgery is reduced due to the higher rate of infection resulting from a longer operation time, increased scar tissue formation, or unrecognized infection at the initial revision operation [264]. Therefore, it is necessary to develop implants with anti-bacterial properties

Table 6. Summary of different methods to immobilize bioactive molecules onto the surface of metallic implants.

**Table 6.** Summary of different methods to immobilize bioactive molecules onto the surface of metallic implants.
Immobilization method		Biological molecule	Substrate and pre-treatment	Results	Ref.
Adsorption		Bone morphogenetic protein-3 (BMP-3)	Corundum-blasted Titanium alloy; Hydroxyapatite coated Titanium alloy; Ti coated Titanium alloy	BMP-3 coated samples showed more ability to induce new bone formation compared to those without BMP-3	[251]
Covalent immobilization	by chemical pretreatment	Synthetic receptor binding motif mimicking BMP-2	3-aminopropyltriethoxysilane (APTES) coated Titanium	enhance the rate of bone healing as compared with untreated Ti surfaces	[252]
		Laminin and human epidermal growth factors (EGF)	Silanized TiO₂-film Silanisation by reaction of GPTS¹	Significantly reduce the amount of irreversibly adsorbed salivary proteins	[253]
		Heparin	Silanized and oxidized Titanium Oxidization by H₂SO₄/30% H₂O₂ or annealing at 750 °C; Silanisation by being boiled in APMS² contained toluene soltution	The remaining activity of heparin is depending on the chain length of spacer	[243]
	by plasma-based modification	Fibronectin	Plasma polymerization of HMDSO³ on Titanium	Enhanced adsorption of fibronectin	[254]
	by plasma-based modification	BMP-4	Plasma polymerization of allyl amine on Titanium alloy	Surfaces with BMP-4 are initially able to induce ALP activity in C3H10T1/2 cells, long term effect is depending on the concentration of surface amino group	[250]
Incorporation with carriers		Recombinant human BMP-2 (rhBMP-2)	Turned or surface etched Titanium dental implant Absorbable Collagen sponge (ACS)	rhBMP-2/ACS significantly enhances the effect of guided bore regeneration (GBR)	[255]
Incorporation with carriers		BMP-2; insulin-like growth factor-1 and transforming growth factor-β1	Titanium Kirschner wires incorporated with poly(D,L-lactide) (PDLLA)	Significantly accelerate the fracture healing	[256,257]

GPTS¹: (3-glycidyloxypropyl)trimethoxysilane; APMS²: 3-(Trimethoxysilyl)-propylamine; HMDSO³: Hexamethyldisiloxane

Implant-associated infections are the results of bacteria adhesion, attendant colonization and the formation of biofilm. The first and most important step for bacteria to interact with the implant is bacterial adhesion on the implant surfaces which is preceded by the adsorption of a conditioning film of small organic compounds and macromolecules [6]. Therefore, inhibiting bacterial adhesion is a crucial step to preventing the implant-associated infection. Based on this knowledge, material scientists have been attempting to incorporate some antibacterial agents to implant surface aiming at inhibiting bacterial adhesion. Anti-bacterial agents for artificial medical implants can be classified into two categories (i.e., inorganic and organic anti-bacterial agent): Organic anti-bacterial agents include antibiotics, such as vancomycin, tobramycin, cephalothin, gentamicin etc. [265], and human and humanised antibodies including IgG, IgA, IgD, IgE and IgM etc. [266]; Inorganic antibacterial agents include Ag-related agents, TiO₂, ZnO and carbon films etc.

4.1. Antibacterial Coatings with Inorganic Agents

Table 7 is a summary of the inorganic agents which have been used or studied to prevent implant-related infections. The antibacterial properties of silver or silver ions and their non-toxicity to mammalian tissue have been known for a long time. The antibacterial mechanism of Ag-related materials has been widely studied [267,268,269]. According to Holt and Bart, silver ions can disrupt the function of bacterial cell membranes, uncouple the respiratory chain from oxidative phosphorylation [265,266], collapse the proton-motive force across the cytoplasmic membrane [270] and interact with thiol groups of membrane-bound enzymes and protein [271]. Also, Ag ions can displace other metal ions that are essential to cell survival, such as Zn and Ca [265].

Ag ions has antibacterial activity against a broad spectrum of pathogens found at the implant sites, including P. aeruginosa, E. coli, S. aureus, and S. epidermidis [265]. In order to give implant antibacterial function, many attempts have been made to incorporate Ag ion or nano-Ag particles to implant surfaces with or without carriers. Various surface modification techniques have been applied to incorporate Ag⁺ ions or Ag nanoparticles into biomedical implant surfaces, including sol-gel [272], ion implantation [273], ion beam assisted deposition [274], plasma electrolytic oxidation [275], solution/evaporation [276] and chemical vapor deposition [277]. Indeed, due to the inherent drawbacks of the metal implants like Ti and Ti alloy, most of the current studies are trying to incorporate Ag or Ag compound into an existing coating or film on the implant surface, so that dual function or multifunction can be achieved. For example, Zhao et al. [274] fabricated Ag/TiN multilayer coatings using ion beam deposition method and demonstrated that the coatings possessed antibacterial function depending on the modulation period. The antibacterial activity of these coatings is mainly affected by the release of Ag⁺ ions [274,276,278]. Therefore factors such as the existing form of silver, the property of host materials and even the particle size [279] and shape [280] can influence the antibacterial activity of the Ag-related coatings. Lok et al. [279] found that only partially oxidized nano-Ag particles exhibited antibacterial activities and the formation of the Ag⁺ on the surface of the nanoparticles was thought to be carriers of chemisorbed Ag⁺ in quantities that are sufficient to mediate antibacterial activities.

Table 7. Summary of inorganic antibacterial agents studied in biomedical coating applications.

**Table 7.** Summary of inorganic antibacterial agents studied in biomedical coating applications.
Inorganic agents		Coatings	Coating methods	Testing bacteria	Note	Ref.
Ag-related agent		TiN/Ag multilayered films	ion beam assisted deposition	E. coli	Antibacterial activity is depending on the modulation period	[284]
		Silver doped perfluoropolyether-urethane coatings	Coating /evapration	P. aeruginosa A. baumannii S. epidermidis	Antibacterial activity is depending on the release of Ag ions	[278]
		TiO₂-Ag coating	Plasma electrolytic oxidation in Ag nanoparticle- contained electrolyte	S. aureus	Possibly, antibacterial activity is due to the close contact of bacteria with Ag particles and the release of Ag ions	[275]
		polyethylene terephthalate implanted with Ag ion	Ion beam implantation	S. epidermidis	Ag exists in the form of Ag₂CO₃ and Ag₂O	[281]
		Poly(vinyl alcohol) / AgNO₃	Solution/evaporation	E. coli and S. aureus	Ag ions can release from the composite coating	[276]
		Silver doped SiO₂ film	Sol-gel	E. coli and S. aureus	Reduction of Ag⁺ ion is affected by the annealing temperature	[272]
Non-Ag agent	F	F^--implanted titanium	Ion implantation	P. gingivalis and A. actinomycetemcomitans	Antibacterial activity was supposed to be caused by the formation of a metal fluoride complex on the surfaces	[282]
	C	Carbon film	Plasma sputtering for H-free film Chemical vapor deposition for α-C:H film	E. coli	α-C:H film showed relatively poor antibacterial activity compared with hydrogen-free carbon films	[283]
	TiO₂	TiO₂ film	plasma source ion implantation followed by annealing	A. actinomycetemcomitans F. nucleatum	Antibacterial activity is due to the photocatalytic bactericidal effect	[284]
		TiO₂ film	A flame-assisted CVD to deposit SiO₂, and thermal APCVD to deposit TiO₂	E. coli		[277]
		DLC films containing TiO₂ nanoparticles	plasma-enhanced chemical vapor deposition	E. coli	Enhanced antibacterial activity are contributed by the increased hydrophilicity and the decreased interfacial energy of bacteria adhesion	[285]
	ZnO	ZnO coated glass	Ultrasonic irradiation	E. coli and S. aureus	The antibacterial activity is due to the generation of the reactive-oxygen-species (ROS) products	[286]

Dowling et al. [287] proved that the addition of small amount of platinum (Pt) enhanced the antibacterial activity of Ag coating as active Pt enhanced the Ag⁺ formation through galvanic action thus favoring the release of Ag⁺. The effects of particles size, shape as well as particle distribution on the antibacterial nano-Ag particle contained coatings were studied by Lok et al. [279] and Pal et al. [280]. Usually, the smaller the particle size is, the better antibacterial activity the particles show [279]. However, reducing the particle size in itself is not the ultimate aim as the antibacterial activity of Ag nanoparticles is also shape-dependent, as previeously reported [280]. Aggregation of nano-sized Ag particles can also lead to a reduction in, or a loss of antibacterial activities [279].

The antibacterial properties of TiO₂-contained materials are based on the photocatalytic bactericidal effect. Under ultraviolet A (UVA) illumination, TiO₂ can decompose various organic compounds and generate active-oxygen species such as reactive-oxygen-species (ROS) products such as super-oxide (O₂⁻), hydroxyl radical (•OH) and hydrogen (H₂O₂) [288]. These decomposition products can kill bacteria in the way that they destroy the outer membrane of bacterial cells, thus causing the cell death [289,290]. The anatase TiO₂ film fabricated by plasma source ion implantation (PSII) followed by annealing, exhibited a strong photocatalytic reaction under UHA illumination and showed a good antibacterial activity in that the viability of Actinobacillus actinomycetemcomitans (A. actinomycetemcomitans) and Fusobacterium nucleatum (F. nucleatum) on the film was inhibited to less than 1% under UVA illumination within 120 min [284]. It is documented that nanosized TiO₂ particles can improve the antibacterial activity of diamond-like carbon films fabricated from plasma-enhanced chemical vapor deposition (PECVD) [291]. Besides the photocatalytic effect, the increased hydrophilicity and the decreased interfacial energy of bacteria adhesion contributed to the enhanced antibacterial activity of TiO₂-contained DLC films.

ZnO is another inorganic antibacterial agent that widely used in the dental cements [292,293]. It shows a marked antibacterial activity in neutral region (pH = 7) even without exposure to light [294]. The anti-bacterial activities of ZnO nanosized powders have been extensively studied. It was reported that the antibacterial activities increased with the decrease in the particle size and the increase in the nanoparticle concentrations. Additionally, the antibacterial activities can be affected by lattice constant (c₀) [295] and crystallographic orientation [296]: Yamamoto et al. [295] revealed that the antibacterial activity of ZnO increased with the increase in c₀ values; Ohira et al. [296] demonstrated that antibacterial activity of ZnO powders with crystallographic orientation was weaker than that of powders without orientation at the same powder concentration. The antibacterial mechanism of ZnO is related to the ROS products such as O₂⁻, •OH and H₂O₂ [297,298], which is similar to that of TiO₂. However, few attempts so far have been made at utilizing the antibacterial properties of ZnO in biomedical implants.

Carbon films process antibacterial activity to a certain extent depending on the chemical composition of the films [283]. It was reported that H-free carbon films showed approximately two times antibacterial activity than α-C:H films. Besides those inorganic antibacterial agents mentioned above, F^- ion implantation can also make titanium antibacterial [254].

4.2. Antibacterial Coatings with Antibiotics and Antibodies

The current clinical strategy to prevent implant-related infection with antibiotics is to treat the patient with a high concentration of antibiotic and this is the so-called systemic administration strategy. Major problems associated with this strategy include poor distribution of the antibacterial agent at the implant site due to limited blood circulation to the infected skeletal tissue, and inability to directly address the biofilm pathogen scenario [299]. Although sometimes high dosage of antibiotics can penetrate tissue or biofilms formed on the implants, toxic side effects are also likely to happen in this case. Researchers are now endeavoring to substitute conventional systemic therapy with a controlled and local antibacterial release system [265]. According to the review by Wu et al. [299], the advantages of controlled release system over the systemic antibiotic therapy can be summed up in the following several points: administration of low dosage when required, greater control over toxicity and bioavailability of dose, less susceptibility to promoting antibiotic resistance, extended duration of release, avoidance of systemic drug exposure and controlled release from the surface of the implant directly to the site.

An ideal antibiotic release system for treating implant-related infection, like all other drug release systems, should provide an appropriate and effective release profile of the antibiotics at the implant site. Namely, a local and controlled release profile should be ideally characterized by a high initial release rate (burst release) followed by a sustainable therapeutic release over a prolonged periods [6,299]. The most common used antibiotics for treating implant-related infection include vancomycin, tobramycin, cefamandol, cephalothin, carbenicillin, amoxicillin and gentamicin [300]. For controlling the release of antibiotics, the antibiotics need to be doped or loaded in a host material which may be polymers (e.g., polyurethane (PU), silicon rubber, poly L-lactic acid (PLA), poly(glycolic acid) (PGA) and polyhydroxyalkanoates (PHA) and polymethylmethacrylate (PMMA)) and inorganic coatings (e.g., hydroxyapatite). Antibacterial coating developed by this approach is referred to as matrix impregnated coatings. The release of the antibiotics is dependent on the loading amount and physiochemical properties of the antibiotics and the properties of the host materials or matrices.

To attain a controlled antibiotic release system with polymer matrices, the polymers are required to have a controllable hydrophilicity which can be realized by changing the ratio of the hydrophilic and the hydrophobic chains [301] and should also have an appropriate balance of biodegradability and biostability [302]. The hydrophilic polymer allows water molecules to diffuse into the matrices, causing the swelling or/and degradation of the polymers, so that antibiotics can be dissolved in water and be eluted out of matrices, while the hydrophobic polymer chains can retain the stability of the matrices in water. In addition, chemical similarity like lipophilicity between the drug and the polymer matrix can lead to homogenous drug distribution within the polymer, which then influences the release profile of the drug [303].

Basak et al. [302] studied the release profile of rifampicin from polyurethane coated implant materials. Polyester urethane coatings with different swelling and degradable properties were synthesized by reacting the ester diol (containing active OH groups) with 2,4-toluene diisocyanate (containing active NCO groups) at different ratio. The swelling of the polyester urethane synthesized from NCO and OH at a ratio of 2.5:1 (PEU2.5) was less than polyester urethane at a ratio of 2:1 (PEU2). The tendency of their degradation behaviors was similar to that of swelling. The release profile of rifampicin from the coatings is characterized by a burst release followed by a sustained release of antibacterial agents. The rifampicin release was dominantly affected by swelling and degradation of the PEU matrices. The burst release, which was supposed to result from that rifampicin bound to the matrix surface and the initial high rate of swelling of the matrix, can help to protect against bacterial adhesion during the most critical period following the implantation [6].

An alternative approach of treating implant-related infections to antibiotic therapy is using immunotherapy with antibodies. Antibodies like IgG, IgA, IgD, IgM and IgE have been proven the most useful as immunotherapeutics [6]. Among them, IgG idiotypes are currently the most attractive antibody therapeutic agent due to their many merits as described in the review paper by Grainger [266]. IgG is a predominant host immune component and is composed of millions of opsonizing antibodies specific to microorganism epitopes. Its antimicrobial or antibacterial activity can be elicited by antiviral binding and neutralization against transfection or by either neutralizing (lethal) binding or opsonisation, promoting F_c receptor-mediated phagocytosis and clearance [6,266]. Polyurethane (PU) [304] and carboxymethylcellulose (CMC) [305] hydrogen have been chosen as the delivery matrices for human IgG. In both cases, there was initial burst release of IgG and both of them reduced infections. Briefly, for the controlled system of PU coating, it was proved that E. coli adhesion to PU coatings loaded with IgG was significantly reduced compared to those coatings without IgG loading [304]; for the controlled system of CMC hydrogel, results of a mouse model showed that 70% of mice provided with IgG-relasing CMC hydrogen inoculated with P. aeruginosa survived after 10 days while there was no survival for mice receiving CMC hydrogen without IgG [305].

Besides polymer coating and hydrogen films, inorganic coatings such as biocompatible HA coatings can also be used as the carrier. Stigter et al. used a biomimetic co-precipitation approach to incorporate an antibiotic (i.e., tobramycin) into HA coatings aiming at preventing post-surgical infections in orthopaedic or trauma [306]. Briefly, amorphous calcium phosphate coatings were first deposited onto the Ti6Al4V plates by immersion in 5 times concentrated SBF for 24 nm at 37 °C, followed by immersion in a supersaturated calcium phosphate solution containing tobramycin for 48 h at 37 °C. Drug release test showed that the release of the tobramycin was depending on the coating dissolution, loading dose and pH values at which the test was conducted. The authors contributed the co-precipitation of tobramycin to the chemical structure and the isoelectric point of tobramycin. Antibacterial test proved that this coating was effective against the S. aureus. In another study [300], antibiotics with carboxylic groups were found to be better incorporated into HA coatings than those without these groups, which further confirmed the great influence of chemical structure of antibiotics on the co-precipitation of the HA and the antibiotics. In order to achieve a long and sustainable release of the antibiotic, some researchers applied a hydrophobic barrier layer (lipid) to retard desorption of antibiotic [307]. However, the lipid layer may reduce the bioactivity of the implant and can cause side effect on the cell adhesion [306]. In a rabbit infection prophylaxis model, gentamicin-incorporated HA coating, fabricated by combination of an electrochemically assisted process and ink jet technology, was proved to have a high potential to contribute to the improvement of infection prophylaxis in cementless total joint arthroplasty [308]. Compared to the biomimetic method, plasma spraying is a high temperature process and it cannot be used to directly load antibiotics in the coatings. However, certain amount of antibiotics like tobramycin can be adsorbed on the plasma sprayed HA coating due to their affinity to hydroxyapatite. Problems with HA coatings presenting antibiotics on their surfaces are that desorption of antibiotics is rapid and the amount of antibiotics adsorbed on the surface is limited [306].

4.3. Nitric Oxide-releasing Antibacterial Coatings

Nitric oxide (NO) is an important regulator and mediator of numerous processes in the nervous, immune and cardiovascular system, including smooth muscle relaxation thus resulting in vasodilation of the artery and increasing blood flow, neurotransmission in the nervous system and macrophage mediated cytotoxicity for microbes and tumor cells [309]. NO can be naturally synthesized in the body by different nitric oxide synthase (NOS). For example, NO can be produced by endothelial nitric oxide synthase (eNOS) under the stimulation of platelet derived factors, shear stress, acetylcholine, and cytokines.

NO can also be synthesized by macrophage during the phagocytosis of bacteria. Exposed to immunostimulants, activated macrophage can produce superoxide (O₂⁻) and NO which can lead to the formation of a much stronger oxidant peroxynitrite (ONOO⁻) [275]. Peroxynitrite could mediate NO-dependent microbial killing [311]. However, there is a time lag between the production of O₂⁻ and NO synthesis as the former is immediate but the later needs several hours’ initiation [312]. This time lag time may allow bacteria to create biofilms thus protecting them from the impending ONOO⁻[310,313]. It is proposed that a supplementary source of NO could favor the ONOO⁻ formation at the initial stage of the colonization when bacteria are most susceptible [310]. Recently, NO-releasing coatings have been proven effective at reducing bacterial adhesion In vitro [265,314,315,316] and inhibiting implant-related infections in vivo [310,317].

NO donors or functional groups that store and release NO include nitrosamines, organic nitrates, metal-NO complexes, N-diazeniumdiolates, and S-nitrosothiols (RSNOs). Diazeniumdiolate NO donors can be formed by reaction of NO with amines under high NO pressure, as shown in Scheme 1 [315]. When exposed to hydrogen donor, such as water, the diazeniumdiolate decompose to NO and corresponding amine precursors.

Scheme 1. Reaction of NO with amines to produce diazeniumdiolate NO donors [315].

Sol-gel chemistry is an easy and effective approach for depositing NO-releasing coatings on biomedical implant surfaces. Briefly, sol is firstly prepared by mixing certain amount of butyltrimethoxysilane (BTMOS), ethanol, water, and hydrochloric acid, followed by adding certain amount of silicon amino-alkoxides (i.e., N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane (AEAP2), (aminoethylaminomethyl) phenylethylethyltrimethoxysilane (AEMP3), N-(6-aminohexyl)-aminopropyltrimethoxysilane (AHAP3), and (3-trimethoxysilylpropyl)-diethylenetriamine (DET3)) [316]. For depositing coatings on implant surfaces, both drop casting and dip coating methods can be used. Nablo et al. deposited NO-releasing coatings on the glass slide and stainless steel substrates using sol-gel methods [310,316,318]. They studied four different amine precursors on their NO releasing behaviors as well as their bacterial activities. A steady rate of NO release was observed for all the sol-gel compositions within 30 min in phosphate buffer solution (PBS), but the level of NO release was dependent on the amount and the type of amine functionality in the films. The release rate increased in the order of DET3 > AHAP3 ≈ AEAP2 > AEMP3. Bacterial adhesion test revealed that these NO releasing coatings could reduce the bacterial (P. aeruginosa) adhesion by 30% to 90% depending on the NO flux from the coatings. At a NO flux less than 1 pmol·s⁻¹·cm²⁻, these coatings lost their antibacterial activity. To assess their efficacy as antibacterial coatings for orthopedic implant applications, they applied NO-releasing coatings to modify stainless steel substrates [319]. Results showed that sol-gel coatings have a better stability on the stainless steel substrates and significantly decreased the bacterial adhesion. To validate the results of In vitro tests, in vivo antibacterial activity of NO-releasing xerogel coatings was further evaluated against an aggressive subcutaneous S. aureus infection in a subcutaneous animal model (rat) [310]. After 8 days of implantation, the number of infected implants with NO-releasing coatings was reduced by 82%. Histological results showed that capsule formed around the NO-releasing implants had greater vascularity compared to those without NO donor or uncoated control [310]. Besides the advantages mentioned above, Hetrick et al. [265] found that NO-releasing coatings may also promote effective device integration into healthy vascularised tissue and diminish foreign body capsule formation.

S-nitrosothiols (RSNO) is another promising NO donor which can be used in implant application. Compared with N-diazeniumdiolates, concerns regarding the formation of potentially toxic by-products are minimal as the RSNO acts as biological transporters of NO in the blood stream [314]. Most of S-nitrosothiols can be formed by the reaction of parent thiols and acidified nitrite (e.g., sodium nitride) [320], which can be called the nitrosation of free thiols. The release of NO from RSNO can be realized by catalytical decomposition by copper (II), copper (I), irradiation with broad-spectrum light， and/or heat etc. More information about the biological role of RSNO can be found in [320].

Riccio et al. [314] fabricated RSNO-modified xerogel by sol-gel method. The RSNO was introduced by the addition of 3-Mercaptopropyltrimethoxysilane (MPTMS) and methyltrimethoxysilane (MTMOS). In their experiments, MPTMS was hydrolyzed and co-condensed with MTMOS which was a backbone alkylalkoxysilanes. The nitrosation of thiols of MPTMS/MTMOS xerogel was via the reaction with acidified nitrite. Results showed that the coatings were capable of producing NO for up to 2 weeks under physiological conditions. The nitrosated coatings which were capable of releasing NO dramatically reduced both platelet and bacterial adhesion without impairing the fibroblast cell viability, indicating that RSNO-modified coatings have the potential use as biomedical coatings [314]. They also proved that the release of NO from RSNO-modified coatings could be triggered by various ways: thermal RSNO decomposition, catalytical decomposition by copper (II), and irradiation with broad-spectrum light. Among them, thermal RSNO decomposition at 37 °C seems to be the best plausible trigger for coatings used as biomedical implants.

4.4. Antimicrobial Peptide Functionalized Films

A more recent utilization of antibacterial agents for biomedical coating application is antimicrobial peptides (AmPs). AmPs generally composed of 15–45 amino acid residues are the effector molecules of innate immunity [321] and are used as a first line of defense against invading pathogens [322]. As AmPs can be produced by insects, fishes, mammalians, and plants, they are often called natural antimicrobial peptide. AmPs have a broad spectrum of antibacterial activity against gram-positive, gram-negative, and multi-drug resistance bacteria [322]. Moreover, they are not likely to cause the bacterial resistance as their antibacterial mechanism is supposed to base on the specific membrane destabilization effect [323,324]. Based on these merits, developing antibacterial coatings with these natural peptides seems very attractive in handling implant-related infections. Table 8 shows some AmPs being used to antibacterially functionalize biomedical films.

Table 8. Summary of antimicrobial peptides (AmPs) used to functionalize films and corresponding incorporation methods.

**Table 8.** Summary of antimicrobial peptides (AmPs) used to functionalize films and corresponding incorporation methods.
Antimicrobial peptides	Amino acid sequence	Coating methods	Ref.
Defensin	ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSKAVCVCRN	LbL	[326]
Chromofungin	RILSILRHQNLLKELQDLAL	LbL	[327]
Magainin I	GIGLPLHSAGLPGLAPVGGIMLS	SAMs	[328]
Gramicidine A	VGALAVVVWLWLWLW	LbL	[321]
LL-37	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	One-pot EISA	[329]
Ponericin G1	GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ	LbL	[322]

Layer-by-layer (LbL) and self assembly monolayers (SAMs) are two often-used surface methods to embed AmPs into films on solid substrate surfaces. LbL deposition is a simple and powerful means for fabricating multilayered coatings with specified compositions and structures. It is based on alternate deposition of oppositely charged materials on solid surfaces with washing steps in between [325]. The practicability of LbL deposition method on embedding AmPs into films is based on the largely cationic composition of AmPs. In this context, AmPs can be simply incorporated in the polyelctrolyte mutilayers by electrostatic adsorption during film construction or through precomplexation with polyanion used for the LbL assembly [326]. Typical processes of embedding AmPs by LbL are depicted in Figure 5. The immobilization of peptides is either through mixing peptides and the polyanions or by adsorption onto the pre-existing polyanion layers.

Figure 5. Typical schematic diagram of layer by layer (LbL) methods: (A) The immobilization of peptides is through mixing peptides and the polyanions. (B) The immobilization of peptides is through adsorption onto the pre-existing polyanion layer.

Several antimicrobial peptides, such as defensin, chromofungin, gramicidine A, ponericin G1, and LL-37, have been successfully embedded into multilayered polyelectrolyte films by LbL methods, as Table 8 shows. Etienne et al. evaluated the antimicrobial and antifungal activity of multilayered films functionalized by defensin [326] and chromofungin [327]. It was proved that both defensin and chromofungin kept their activity after incorporation into polyelectrolyte films. In more detail, the defensin-functionalized films could inhibit the growth of E. Coli D22 by 98% [326]; films functionalized with chromofungin was able to inhibit the growth of yeast Candida albicans by 65% and completely inhibit the proliferation of filamentous fungus Neurospora crassa by interacting with the fungal membrane and penetrating into the cells [327]. In the former study, it was observed that the antibacterial activity of the peptides only had effects on those bacteria in close contact with the films for a sufficient time; as a result, the adhesion mechanism was proposed [326]. However, an ideal antibacterial film is required to be not only capable of killing those bacteria attaching on its surface, but also those present around the surrounding tissues or fluids. Therefore, just like other antibacterial coatings, AmPs-functionalized films should also be designed to possess a localized and sustainable release of AmPs to the surrounding meida. Guyomard et al. [321] demonstrated that the release of gramicidine A from the amphiphilic polyelectrolyte multilayered films was also active against gram-positive bacteria E. faecails. But the release profile was not accurately measured in this work. Shukla et al. [322] incorporated ponericin G1 into a hydrolytically degradable polyelectrolyte multilayer film to get a controlled release profile. Three different polyanions (i.e., alginic acid, dextran sulfate, and chondroitin) were used and their effects on film growth, ponericin G1 loading and release were investigated. Dextran sulfate film grew slower than that of alginic acid and chondroiyin due to its much higher molecular weight, as higher molecular species had a slow diffusion process [322]. Accordingly, films with different polyanions possessed different thickness after the same deposition cycles, which directly influenced the ponericin G1 loading amount in the films. Besides film thickness, chemical property is also an influencing factor in ponericin G1 loading and release. The film growth profile and the final thickness of the alginic acid and chondroitin were similar, but their release profile differed from each other as their negative-charged groups interacting with ponericin G1 were different. Antibacterial assay and cell culture test showed that Ponercin G1 could retain its antibacterial activity in all films without compromising their cytocompatibility [322].

Humblot et al. [328] immobilized magainins I onto gold surfaces by SAMs. Firstly, the gold-sputtered glass substrates were immersed in a binary mixture of 11-mercaptoundecanoic (MUA) and 6-mercaptohexanol (C6OH). Secondly, the substrates with ad-layers were exposed to a solution of N-hydroxysuccinimide (NHS) and 1-(3-dimethyllaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) to convert the carboxylic acid tail groups of MUA into esters function. Finally, magainins were covalently immobilized onto the treated surfaces. The antibacterial activity test showed that more than 50% bacterial cells in contact with the magainins I immobilized surface were killed by modifying the walls of the cell and inducing the formation of pores on outer bacterial membranes. The antibacterial mode was thought to be bacteriostatic [328].

Figure 6. Schematic map of the incorporation of LL-37 into mesoporous silica films by one-pot EISA [329].

Izquierdo-Barba et al. [329] utilized a one-pot evaporation-induced self-assembly (EISA) method to incorporate antimicrobial peptide LL-37 into mesoporous silica films and obtained a sustainable release of the LL-37. The incorporation process of LL-37 peptides into the mesoporous silica films is shown in Figure 6. One-pot EISA method is an improved one pot method which runs at a low reaction temperature and suitable for incorporation of highly water soluble proteins and peptides [329]. It was observed that the release of LL-37 from the films was sustainable and the released amount reached the maximum after about 200 h. Moreover, the release rate could be controlled by incorporating SH groups in the pore walls by 3-mercaptopropyltrimethoxysilane (MPTS). Antibacterial activity test showed that LL-37 incorporated film displayed potency against both Gram-positive S. aureus and Gram-negative E. Coli, indicating its potential use as a biomedical films handling the implant-associated infections.

5. Summary

Metallic materials are widely used in biomedical field as orthopaedic and dental implants, as well as cardiovascular devices. However, problems associated with metal implants are limiting their uses and still causing some undesired side effects. Large amount of coatings have been applied to metallic implants with variety of surface modification techniques, however, few studied coatings have multi-functions and few of them have come into clinical use. Therefore, tremendous work should still be done to validate the existing potential coatings and develop new candidates. Multi-functional coatings may be one of the research goals.

Acknowledgements

The authors are grateful for the financial support of the National Health and Medical Research Council and the Australia and the Australian Research Council.

References

Niinomi, M. Metallic biomaterials. J. Artif. Organs 2008, 11, 105–110. [Google Scholar] [CrossRef] [PubMed]
Patterson, S.P.; Daffner, R.H.; Gallo, R.A. Electrochemical corrosion of metal implants. AJR. Am. J. Roentgenol. 2005, 184, 1219–1222. [Google Scholar] [CrossRef] [PubMed]
Ingham, E.; Fisher, J. Biological reaction to wear debris in total joint replacement. Proc. Inst. Mech. Eng. H 2000, 214, 21–37. [Google Scholar] [CrossRef] [PubMed]
Spector, M. Biomaterial failure. Orthop. Clin. North. Am. 1992, 23, 211–217. [Google Scholar] [PubMed]
Willmann, G. Coating of Implants with Hydroxyapatite—Material Connections between Bone and Metal. Adv. Eng. Mater. 1999, 1, 95–105. [Google Scholar] [CrossRef]
Hetrick, E.M.; Schoenfisch, M.H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev. 2006, 35, 780–789. [Google Scholar] [CrossRef] [PubMed]
Wong, J.Y.; Bronzino, J.D. Biomaterials, 2nd ed; CRC Press: Boca Raton, FL, USA, 2007. [Google Scholar]
Peracchia, G.; Bobbio, P.; Vecchi, P. Effects of the introduction of a wire of radioactive tantalum (Ta-182) into the internal mammary artery. Experimental research. Boll. Soc. Ital. Biol. Sper. 1961, 37, 832–834. [Google Scholar] [PubMed]
Mudali, U.K.; Sridhar, T.M.; RAJ, B. Corrosion of bio implants. Sadhana 2003, 28, 601–637. [Google Scholar] [CrossRef]
Siva Rama Krishna, D.; Brama, Y.L.; Sun, Y. Thick rutile layer on titanium for tribological applications. Tribol. Int. 2007, 40, 329–334. [Google Scholar] [CrossRef]
García-Alonso, M.C.; Saldaña, L.; Vallés, G.; González-Carrasco, J.L.; González-Cabrero, J.; Martínez, M.E.; Gil-Garay, E.; Munuera, L. In vitro corrosion behaviour and osteoblast response of thermally oxidised Ti6Al4V alloy. Biomaterials 2003, 24, 19–26. [Google Scholar] [CrossRef] [PubMed]
Dearnley, P.A.; Dahm, K.L.; Çimenoglu, H. The corrosion-wear behaviour of thermally oxidised CP-Ti and Ti-6Al-4V. Wear 2004, 256, 469–479. [Google Scholar] [CrossRef]
Borgioli, F.; Galvanetto, E.; Iozzelli, F.; Pradelli, G. Improvement of wear resistance of Ti-6Al-4V alloy by means of thermal oxidation. Mater. Lett. 2005, 59, 2159–2162. [Google Scholar] [CrossRef]
Guleryuz, H.; Cimenoglu, H. Surface modification of a Ti-6Al-4V alloy by thermal oxidation. Surf. Coat. Tech. 2005, 192, 164–170. [Google Scholar] [CrossRef]
Xia, J.; Li, C.X.; Dong, H.; Bell, T. Nanoindentation and nanoscratch properties of a thermal oxidation treated [gamma]-TiAl based alloy. Surf. Coat. Tech. 2006, 200, 4755–4762. [Google Scholar] [CrossRef]
Siva Rama Krishna, D.; Sun, Y. Effect of thermal oxidation conditions on tribological behaviour of titanium films on 316L stainless steel. Surf. Coat. Tech. 2005, 198, 447–453. [Google Scholar] [CrossRef]
Lavisse, L.; Grevey, D.; Langlade, C.; Vannes, B. The early stage of the laser-induced oxidation of titanium substrates. Appl. Surf. Sci. 2002, 186, 150–155. [Google Scholar] [CrossRef]
Dong, H.; Bell, T. Enhanced wear resistance of titanium surfaces by a new thermal oxidation treatment. Wear 2000, 238, 131–137. [Google Scholar] [CrossRef]
Güleryüz, H.; Çimenoglu, H. Effect of thermal oxidation on corrosion and corrosion-wear behaviour of a Ti-6Al-4V alloy. Biomaterials 2004, 25, 3325–3333. [Google Scholar] [CrossRef] [PubMed]
Dong, H.; Li, X.Y. Oxygen boost diffusion for the deep-case hardening of titanium alloys. Mater. Sci. Eng. A 2000, 280, 303–310. [Google Scholar] [CrossRef]
Saldaña, L.; Vilaboa, N.; Vallés, G.; González-Cabrero, J.; Munuera, L. Osteoblast response to thermally oxidized Ti6Al4V alloy. J. Biomed. Mater. Res. A 2005, 73A, 97–107. [Google Scholar] [CrossRef] [PubMed]
Xue, W.; Wang, C.; Chen, R.; Deng, Z. Structure and properties characterization of ceramic coatings produced on Ti-6Al-4V alloy by microarc oxidation in aluminate solution. Mater. Lett. 2002, 52, 435–441. [Google Scholar] [CrossRef]
Rama Krishna, L.; Somaraju, K.R.C.; Sundararajan, G. The tribological performance of ultra-hard ceramic composite coatings obtained through microarc oxidation. Surf. Coat. Tech. 2003, 163-164, 484–490. [Google Scholar] [CrossRef]
Liang, J.; Hu, L.; Hao, J. Improvement of corrosion properties of microarc oxidation coating on magnesium alloy by optimizing current density parameters. Appl. Surf. Sci. 2007, 253, 6939–6945. [Google Scholar] [CrossRef]
Guo, H.F.; An, M.Z. Growth of ceramic coatings on AZ91D magnesium alloys by micro-arc oxidation in aluminate-fluoride solutions and evaluation of corrosion resistance. Appl. Surf. Sci. 2005, 246, 229–238. [Google Scholar] [CrossRef]
Liang, J.; Guo, B.; Tian, J.; Liu, H.; Zhou, J.; Xu, T. Effect of potassium fluoride in electrolytic solution on the structure and properties of microarc oxidation coatings on magnesium alloy. Appl. Surf. Sci. 2005, 252, 345–351. [Google Scholar] [CrossRef]
Chen, F.; Zhou, H.; Yao, B.; Qin, Z.; Zhang, Q. Corrosion resistance property of the ceramic coating obtained through microarc oxidation on the AZ31 magnesium alloy surfaces. Surf. Coat. Tech. 2007, 201, 4905–4908. [Google Scholar] [CrossRef]
Liang, J.; Hu, L.; Hao, J. Characterization of microarc oxidation coatings formed on AM60B magnesium alloy in silicate and phosphate electrolytes. Appl. Surf. Sci. 2007, 253, 4490–4496. [Google Scholar] [CrossRef]
Guo, H.; An, M. Effect of surfactants on surface morphology of ceramic coatings fabricated on magnesium alloys by micro-arc oxidation. Thin Solid Films 2006, 500, 186–189. [Google Scholar] [CrossRef]
Cai, Q.; Wang, L.; Wei, B.; Liu, Q. Electrochemical performance of microarc oxidation films formed on AZ91D magnesium alloy in silicate and phosphate electrolytes. Surf. Coat. Tech. 2006, 200, 3727–3733. [Google Scholar] [CrossRef]
Guo, H.; An, M.; Xu, S.; Huo, H. Microarc oxidation of corrosion resistant ceramic coating on a magnesium alloy. Mater. Lett. 2006, 60, 1538–1541. [Google Scholar] [CrossRef]
Chu, P.K.; Chen, J.Y.; Wang, L.P.; Huang, N. Plasma-surface modification of biomaterials. Mater. Sci. Eng.: R 2002, 36, 143–206. [Google Scholar] [CrossRef]
Leng, Y.X.; Chen, J.Y.; Zeng, Z.M.; Tian, X.B.; Yang, P.; Huang, N.; Zhou, Z.R.; Chu, P.K. Properties of titanium oxide biomaterials synthesized by titanium plasma immersion ion implantation and reactive ion oxidation. Thin Solid Films 2000, 377-378, 573–577. [Google Scholar] [CrossRef]
Liu, X.; Chu, P.K.; Ding, C. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater. Sci. Eng.: R 2004, 47, 49–121. [Google Scholar] [CrossRef]
Tan, L.; Crone, W.C. Surface characterization of NiTi modified by plasma source ion implantation. Acta Mater. 2002, 50, 4449–4460. [Google Scholar] [CrossRef]
Tan, L.; Dodd, R.A.; Crone, W.C. Corrosion and wear-corrosion behavior of NiTi modified by plasma source ion implantation. Biomaterials 2003, 24, 3931–3939. [Google Scholar] [CrossRef] [PubMed]
Tan, L.; Shaw, G.; Sridharan, K.; Crone, W.C. Effects of oxygen ion implantation on wear behavior of NiTi shape memory alloy. Mech. Mater. 2005, 37, 1059–1068. [Google Scholar] [CrossRef]
Lima Neto, P.; Atik, M.; Avaca, L.A.; Aegerter, M.A. Sol-gel coatings for chemical protection of stainless steel. J. Sol-Gel Sci. Technol. 1994, 2, 529–534. [Google Scholar] [CrossRef]
Liu, J.X.; Yang, D.Z.; Shi, F.; Cai, Y.J. Sol-gel deposited TiO₂ film on NiTi surgical alloy for biocompatibility improvement. Thin Solid Films 2003, 429, 225–230. [Google Scholar] [CrossRef]
Zhang, W.; Liu, W.; Wang, C. Tribological behavior of sol-gel TiO₂ films on glass. Wear 2002, 253, 377–384. [Google Scholar] [CrossRef]
Jia, Q.; Zhang, Y.; Wu, Z.; Zhang, P. Tribological properties of anatase TiO₂ sol-gel films controlled by mutually soluble dopants. Tribol. Lett. 2007, 26, 19–24. [Google Scholar] [CrossRef]
Zhang, W.; Wang, C.; Liu, W. Characterization and tribological investigation of sol-gel ceramic films on Ti-6Al-4V. Wear 2006, 260, 379–386. [Google Scholar] [CrossRef]
Zhang, W.G.; Liu, W.M.; Liu, Y.; Wang, C.T. Tribological behaviors of single and dual sol-gel ceramic films on Ti-6Al-4V. Ceram. Int. 2009, 35, 1513–1520. [Google Scholar] [CrossRef]
Keceli, S.A.; Alanyali, H. A Study on the Evaluation of the Cytotoxicity of Al₂O₃, Nb₂O₅, Ta₂O₅, TiO₂ and ZrO₂. Turkish J. Eng. Env. Sci. 2004, 28, 49–54. [Google Scholar]
Wang, Y.; Jin, Y.; Wen, S. The analysis of the friction and wear mechanisms of plasma-sprayed ceramic coatings at 450 °C. Wear 1988, 128, 265–276. [Google Scholar] [CrossRef]
Dai, W.W.; Ding, C.X.; Li, J.F.; Zhang, Y.F.; Zhang, P.Y. Wear mechanism of plasma-sprayed TiO2 coating against stainless steel. Wear 1996, 196, 238–242. [Google Scholar] [CrossRef]
Ibrahim, A.; Lima, R.S.; Berndt, C.C.; Marple, B.R. Fatigue and mechanical properties of nanostructured and conventional titania (TiO₂) thermal spray coatings. Surf. Coat. Tech. 2007, 201, 7589–7596. [Google Scholar] [CrossRef]
Fervel, V.; Normand, B.; Coddet, C. Tribological behavior of plasma sprayed Al₂O₃-based cermet coatings. Wear 1999, 230, 70–77. [Google Scholar] [CrossRef]
Ahn, H.S.; Kim, J.Y. Lim, D.S. Tribological behaviour of plasma-sprayed zirconia coatings. Wear 1997, 203-204, 77–87. [Google Scholar] [CrossRef]
Yilmaz, R.; Kurt, A.O.; Demir, A.; TatlI, Z. Effects of TiO₂ on the mechanical properties of the Al₂O₃-TiO₂ plasma sprayed coating. J. Eur. Ceram. Soc. 2007, 27, 1319–1323. [Google Scholar] [CrossRef]
Yang, C.; Bahadur, S. Friction and wear behavior of alumina-based ceramics in dry and lubricated sliding against tool steel. Wear 1992, 157, 263–277. [Google Scholar] [CrossRef]
Zum Gahr, K.H.; Bundschuh, W.; Zimmerlin, B. Effect of grain size on friction and sliding wear of oxide ceramics. Wear 1993, 162-164, 269–279. [Google Scholar] [CrossRef]
Fauchais, P.; Etchart-Salas, R.; Rat, V.; Coudert, J.F.; Caron, N.; Wittmann-Ténèze, K. Parameters Controlling Liquid Plasma Spraying: Solutions, Sols, or Suspensions. J. Therm. Spray Technol. 2008, 17, 31–59. [Google Scholar] [CrossRef]
He, C.; Wang, Y.S.; Wallace, J.S.; Hsu, S.M. Effect of microstructure on the wear transition of zirconia-toughened alumina. Wear 1993, 162-164, 314–321. [Google Scholar] [CrossRef]
Chen, H.; Ding, C.; Zhang, P.; La, P.; Lee, S.W. Wear of plasma-sprayed nanostructured zirconia coatings against stainless steel under distilled-water conditions. Surf. Coat. Tech. 2003, 173, 144–149. [Google Scholar] [CrossRef]
Kerkwijk, B.; Winnubst, A.J.A.; Verweij, H.; Mulder, E.J.; Metselaar, H.S.C.; Schipper, D.J. Tribological properties of nanoscale alumina-zirconia composites. Wear 1999, 225-229, 1293–1302. [Google Scholar] [CrossRef]
Lin, X.; Zeng, Y.; Ding, C.; Zhang, P. Effects of temperature on tribological properties of nanostructured and conventional Al₂O₃-3 wt.% TiO₂ coatings. Wear 2004, 256, 1018–1025. [Google Scholar] [CrossRef]
Fu, Y.; Batchelor, A.W.; Xing, H.; Gu, Y. Wear behaviour of laser-treated plasma-sprayed ZrO₂ coatings. Wear 1997, 210, 157–164. [Google Scholar] [CrossRef]
Yang, Y.; Zhu, Y.; Liu, Z.; Chuang, Y. Laser remelting of plasma sprayed Al₂O₃ ceramic coatings and subsequent wear resistance. Mater. Sci. Eng. A 2000, 291, 168–172. [Google Scholar] [CrossRef]
Xin, Y.C.; Liu, C.L.; Huo, K.F.; Tang, G.Y.; Tian, X.B.; Chu, P.K. Corrosion behavior of ZrN/Zr coated biomedical AZ91 magnesium alloy. Surf. Coat. Tech. 2009, 203, 2554–2557. [Google Scholar] [CrossRef]
Yan, C.; Zheng, Y.F. A study of ZrN/Zr coatings deposited on NiTi alloy by PIIID technique. IEEE Trans. Plasma Sci. 2006, 34, 1105–1108. [Google Scholar] [CrossRef]
Hübler, R.; Cozza, A.; Marcondes, T.L.; Souza, R.B.; Fiori, F.F. Wear and corrosion protection of 316-L femoral implants by deposition of thin films. Surf. Coat. Tech. 2001, 142-144, 1078–1083. [Google Scholar] [CrossRef]
Hendry, J.A.; Pilliar, R.M. The fretting corrosion resistance of PVD surface-modified orthopedic implant alloys. J. Biomed. Mater. Res. 2001, 58, 156–166. [Google Scholar] [CrossRef] [PubMed]
Chou, W.J.; Yu, G.P.; Huang, J.H. Corrosion resistance of ZrN films on AISI 304 stainless steel substrate. Surf. Coat. Tech. 2003, 167, 59–67. [Google Scholar] [CrossRef]
Kertzman, Z.; Marchal, J.; Suarez, M.; Staia, M.H.; Filip, P.; Kohli, P.; Aouadi, S.M. Mechanical, tribological, and biocompatibility properties of ZrN-Ag nanocomposite films. J. Biomed. Mater. Res. A 2008, 84, 1061–1067. [Google Scholar] [CrossRef] [PubMed]
Kelesoglu, E.; Mitterer, C.; Ürgen, M. Corrosion characteristics of plain carbon steel coated with TiN and ZrN under high-flux ion bombardment. Surf. Coat. Tech. 2002, 160, 82–86. [Google Scholar] [CrossRef]
Gispert, M.P.; Serro, A.P.; Colaco, R.; do Rego, A.M.B.; Alves, E.; da Silva, R.C.; Brogueira, P.; Pires, E.; Saramago, B. Tribological behaviour of Cl-implanted TiN coatings for biomedical applications. Wear 2007, 262, 1337–1345. [Google Scholar] [CrossRef]
Kao, C.T.; Ding, S.J.; Chen, Y.C.; Huang, T.H. The anticorrosion ability of titanium nitride (TiN) plating on an orthodontic metal bracket and its biocompatibility. J. Biomed. Mater. Res. 2002, 63, 786–792. [Google Scholar] [CrossRef] [PubMed]
Cheng, Y.; Zheng, Y.F. Formation of TiN films on biomedical NiTi shape memory alloy by PIIID. Mater. Sci. Eng. A Struct. Mater. 2006, 434, 99–104. [Google Scholar] [CrossRef]
Li, Y.; Qu, L.; Wang, F. The electrochemical corrosion behavior of TiN and (Ti,Al)N coatings in acid and salt solution. Corr. Sci. 2003, 45, 1367–1381. [Google Scholar] [CrossRef]
Liu, C.; Bi, Q.; Matthews, A. Tribological and electrochemical performance of PVD TiN coatings on the femoral head of Ti-6Al-4V artificial hip joints. Surf. Coat. Tech. 2003, 163-164, 597–604. [Google Scholar] [CrossRef]
Monticelli, C.; Zucchi, F.; Tampieri, A. Triboelectrochemical behaviour of a Si₃N₄-TiN ceramic composite and a titanium alloy commonly used in biomedical applications. Wear 2009, 266, 327–336. [Google Scholar] [CrossRef]
Kumar, A.; Kaur, D. Nanoindentation and corrosion studies of TiN/NiTi thin films for biomedical applications. Surf. Coat. Tech. 2009, 204, 1132–1136. [Google Scholar] [CrossRef]
Liu, C.L.; Lin, G.Q.; Yang, D.Z.; Qi, M. In vitro corrosion behavior of multilayered Ti/TiN coating on biomedical AISI 316L stainless steel. Surf. Coat. Tech. 2006, 200, 4011–4016. [Google Scholar] [CrossRef]
Cheng, Y.; Zheng, Y.F. A study of ZrN/Zr coatings deposited on NiTi alloy by PIIID technique. IEEE Trans. Plasma Sci. 2006, 34, 1105–1108. [Google Scholar] [CrossRef]
Fu, Y.Q.; Du, H.J.; Zhang, S. Deposition of TiN layer on TiNi thin films to improve surface properties. Surf. Coat. Tech. 2003, 167, 129–136. [Google Scholar] [CrossRef]
da Silva, L.L.G.; Ueda, M.; Silva, M.M.; Codaro, E.N. Corrosion behavior of Ti-6Al-4V alloy treated by plasma immersion ion implantation process. Surf. Coat. Tech. 2007, 201, 8136–8139. [Google Scholar] [CrossRef]
Pelletier, J.; Anders, A. Plasma-blased ion implantation and deposition: A review of physics, technology, and applications. IEEE Trans. Plasma Sci. 2005, 33, 1944–1959. [Google Scholar] [CrossRef]
Oztarhan, A.; Brown, I.; Bakkaloglu, C.; Watt, G.; Evans, P.; Oks, E.; Nikolaev, A.; Tek, Z. Metal vapour vacuum arc ion implantation facility in Turkey. Surf. Coat. Tech. 2005, 196, 327–332. [Google Scholar] [CrossRef]
Ueda, M.; Gomes, G.F.; Kostov, K.G.; Reuther, H.; Lepienski, C.M.; Soares, P.C.; Takai, O.; Silva, M.M. Results from experiments on hybrid plasma immersion ion implantation/nitriding processing of materials. Braz. J. Phys. 2004, 34, 1632–1637. [Google Scholar] [CrossRef]
Lei, M.K.; Zhang, Z.L.; Ma, T.C. Plasma-based low-energy ion implantation for low-temperature surface engineering. Surf. Coat. Tech. 2000, 131, 317–325. [Google Scholar] [CrossRef]
Abadias, G. Stress and preferred orientation in nitride-based PVD coatings. Surf. Coat. Tech. 2008, 202, 2223–2235. [Google Scholar] [CrossRef]
Vadiraj, A.; Kamaraj, M.; Gnanomoorthy, R. Fretting wear studies on PVD TiN coated, ion implanted and thermally oxidised biomedical titanium alloys. Surf. Eng. 2007, 23, 209–215. [Google Scholar] [CrossRef]
Rodríguez, R.J.; García, J.A.; Medrano, A.; Rico, M.; Sánchez, R.; Martínez, R.; Labrugère, C.; Lahaye, M.; Guette, A. Tribological behaviour of hard coatings deposited by arc-evaporation PVD. Vacuum 2002, 67, 559–566. [Google Scholar] [CrossRef]
Ochoa, E.A.; Figueroa, C.A. Influence of the microstructure on steel hardening in pulsed plasma nitriding. J. Vac. Sci. Technol. A 2008, 26, 328–332. [Google Scholar] [CrossRef]
Clem, W.C.; Konovalov, V.V.; Chowdhury, S.; Vohra, Y.K.; Catledge, S.A.; Bellis, S.L. Mesenchymal stem cell adhesion and spreading on microwave plasma-nitrided titanium alloy. J. Biomed. Mater. Res. A 2006, 76A, 279–287. [Google Scholar] [CrossRef] [PubMed]
Fu, R.K.Y.; Kwok, S.C.H.; Chen, P.; Yang, P.; Ngai, R.H.C.; Tian, X.B.; Chu, P.K. Surface modification of cemented carbide using plasma nitriding and metal ion implantation. Surf. Coat. Tech. 2005, 196, 150–154. [Google Scholar] [CrossRef]
Sun, F.J.; Liu, J.Y.; Yang, Y.L.; Yu, H.J. Nitridation of iron by CW-CO₂ laser nitriding technologies. Mater. Sci. Eng. B 2005, 122, 29–33. [Google Scholar] [CrossRef]
Schaaf, P.; Han, M.; Lieb, K.P.; Carpene, E. Laser nitriding of iron with laser pulses from femtosecond to nanosecond pulse duration. Appl. Phys. Lett. 2002, 80, 1091–1093. [Google Scholar] [CrossRef]
Schaaf, P. Laser nitriding of metals. Prog. Mater. Sci. 2002, 47, 1–161. [Google Scholar] [CrossRef]
Li, D.J.; Cui, F.Z.; Gu, H.Q. Studies of diamond-like carbon films coated on PMMA by ion beam assisted deposition. Appl. Surf. Sci. 1999, 137, 30–37. [Google Scholar] [CrossRef]
Ma, W.J.; Ruys, A.J.; Mason, R.S.; Martin, P.J.; Bendavid, A.; Liu, Z.W.; Ionescu, M.; Zreiqat, H. DLC coatings: Effects of physical and chemical properties on biological response. Biomaterials 2007, 28, 1620–1628. [Google Scholar] [CrossRef] [PubMed]
Seung, L.C.; Lee, K.R.; Yong, E.K.; Hyun, Y.K.; Hee, H.J. Structure and properties of Si incorporated tetrahedral amorphous carbon films prepared by hybrid filtered vacuum arc process. Diam. Relat. Mater. 2002, 11, 198–203. [Google Scholar] [CrossRef]
Zou, Y.S.; Wang, W.; Song, G.H.; Du, H.; Gong, J.; Huang, R.F.; Wen, L.S. Influence of the gas atmosphere on the microstructure and mechanical properties of diamond-like carbon films by arc ion plating. Mater. Lett. 2004, 58, 3271–3275. [Google Scholar] [CrossRef]
Thorwarth, G.; Hammerl, C.; Kuhn, M.; Assmann, W.; Schey, B.; Stritzker, B. Investigation of DLC synthesized by plasma immersion ion implantation and deposition. Surf. Coat. Tech. 2005, 193, 206–212. [Google Scholar] [CrossRef]
Sánchez, N.A.; Rincón, C.; Zambrano, G.; Galindo, H.; Prieto, P. Characterization of diamond-like carbon (DLC) thin films prepared by r.f. magnetron sputtering. Thin Solid Films 2000, 373, 247–250. [Google Scholar] [CrossRef]
He, X.M.; Li, W.Z.; Li, H.D. Structure and properties of carbon nitride films synthesized by low energy ion bombardment. J. Mater. Res. 1997, 12, 1595–1602. [Google Scholar] [CrossRef]
Shim, K.S.; Kim, S.M.; Bae, S.H.; Lee, S.Y.; Jung, H.S.; Park, H.H. Fabrication and characterization of diamond-like carbon thin films by pulsed laser deposition. Appl. Surf. Sci. 2000, 154-155, 482–484. [Google Scholar] [CrossRef]
Kalish, R.; Lifshitz, Y.; Nugent, K.; Prawer, S. Thermal stability and relaxation in diamond-like-carbon. A Raman study of films with different sp³ fractions (ta-C to a-C). Appl. Phys. Lett. 1999, 74, 2936–2938. [Google Scholar] [CrossRef]
Kulik, J.; Lifshitz, Y.; Lempert, G.D.; Rabalais, J.W.; Marton, D. Erectron-energy-loss spectroscopy of mass-selected ion-beam-deposited diamond-like carbon. J. Appl. Phys. 1994, 76, 5063–5069. [Google Scholar] [CrossRef]
Erdemir, A.; Donnet, C. Tribology of diamond-like carbon films: recent progress and future prospects. J. Phy D Appl. Phys. 2006, 39, R311–R327. [Google Scholar] [CrossRef]
Grill, A. Diamond-like carbon coatings as biocompatible materials—An overview. Diam. Relat. Mater. 2003, 12, 166–170. [Google Scholar] [CrossRef]
Bhushan, B. Chemical, mechanical and tribological characterization of ultra-thin and hard amorphous carbon coatings as thin as 3.5 nm: recent developments. Diam. Relat. Mater. 1999, 8, 1985–2015. [Google Scholar] [CrossRef]
Robertson, J. Diamond-like amorphous carbon. Mater. Sci. Eng. R Rep. 2002, 37, 129–281. [Google Scholar] [CrossRef]
Dearnaley, G.; Arps, J.H. Biomedical applications of diamond-like carbon (DLC) coatings: A review. Surf. Coat. Tech. 2005, 200, 2518–2524. [Google Scholar] [CrossRef]
Hauert, R. A review of modified DLC coatings for biological applications. Diam. Relat. Mater. 2003, 12, 583–589. [Google Scholar] [CrossRef]
Bhushan, B.; Kellock, A.J.; Cho, N.H.; Ager, J.W. Characterization of chemical bonding and physical characteristics of diamond-like amorphous carbon and diamond films. J. Mater. Res. 1992, 7, 404–410. [Google Scholar] [CrossRef]
Ronkainen, H.; Varjus, S.; Holmberg, K. Tribological performance of different DLC coatings in water-lubricated conditions. Wear 2001, 249, 267–271. [Google Scholar] [CrossRef]
Fisher, J.; Firkins, P.; Reeves, E.A.; Hailey, J.L.; Isaac, G.H. The influence of scratches to metallic counterfaces on the wear of ultra‐high molecular weight polyethylene. ARCHIVE: Proc. Inst. Mech. Eng. H J. Eng. Med. 1995, 209, 263–264. [Google Scholar] [CrossRef]
Jiang, J.; Arnell, R.D. The effect of substrate surface roughness on the wear of DLC coatings. Wear 2000, 239, 1–9. [Google Scholar] [CrossRef]
Ikeyama, M.; Nakao, S.; Miyagawa, Y.; Miyagawa, S. Effects of Si content in DLC films on their friction and wear properties. Surf. Coat. Tech. 2005, 191, 38–42. [Google Scholar] [CrossRef]
Meneve, J.; Jacobs, R.; Eersels, L.; Smeets, J.; Dekempeneer, E. Friction and wear behaviour of amorphous hydrogenated Si1-x Cx films. Surf. Coat. Tech. 1993, 62, 577–582. [Google Scholar] [CrossRef]
Neerinck, D.; Persoone, P.; Sercu, M.; Goel, A.; Venkatraman, C.; Kester, D.; Halter, C.; Swab, P.; Bray, D. Diamond-like nanocomposite coatings for low-wear and low-friction applications in humid environments. Thin Solid Films 1998, 317, 402–404. [Google Scholar] [CrossRef]
Sheeja, D.; Tay, B.K.; Lau, S.P.; Shi, X.; Ding, X. Structural and tribological characterization of multilayer ta-C films prepared by filtered cathodic vacuum arc with substrate pulse biasing. Surf. Coat. Tech. 2000, 132, 228–232. [Google Scholar] [CrossRef]
Roy, R.K.; Lee, K.R. Biomedical applications of diamond-like carbon coatings: A review. J. Biomed. Mater. Res. B Appl. Biomater. 2007, 83B, 72–84. [Google Scholar] [CrossRef] [PubMed]
Park, J.; Lakes, R.S. Biomaterials, 3rd ed.; Springer Science + Business Media: New York, NY, USA, 2007. [Google Scholar]
Kokubo, T. Bioactive glass ceramics: properties and applications. Biomaterials 1991, 12, 155–63. [Google Scholar] [CrossRef] [PubMed]
Kokubo, T.; Takadama, H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006, 27, 2907–2915. [Google Scholar] [CrossRef] [PubMed]
Puleo, D.A.; Nanci, A. Understanding and controlling the bone-implant interface. Biomaterials 1999, 20, 2311–21. [Google Scholar] [CrossRef] [PubMed]
Paital, S.R.; Dahotre, N.B. Calcium phosphate coatings for bio-implant applications: Materials, performance factors, and methodologies. Mater. Sci. Eng. R Rep. 2009, 66, 1–70. [Google Scholar] [CrossRef]
Dorozhkin, S.V.; Epple, M. Biological and medical significance of calcium phosphates. Angew. Chem. Int. Ed. Engl. 2002, 41, 3130–3146. [Google Scholar] [CrossRef] [PubMed]
Bohner, M. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements. Injury 2000, 31, D37–D47. [Google Scholar] [CrossRef]
Jaffe, W.L.; Scott, D.F. Current concepts review—Total hip Arthroplasty with hydroxyapatite-coated prostheses. J. Bone Joint Surg. Am. 1996, 78, 1918–1934. [Google Scholar] [PubMed]
Choi, J.; Bogdanski, D.; Köller, M.; Esenwein, S.A.; Müller, D.; Muhr, G.; Epple, M. Calcium phosphate coating of nickel-titanium shape-memory alloys. Coating procedure and adherence of leukocytes and platelets. Biomaterials 2003, 24, 3689–3696. [Google Scholar] [CrossRef] [PubMed]
Grandfield, K.; Sun, F.; FitzPatrick, M.; Cheong, M.; Zhitomirsky, I. Electrophoretic deposition of polymer-carbon nanotube-hydroxyapatite composites. Surf. Coat. Tech. 2009, 203, 1481–1487. [Google Scholar] [CrossRef]
Herø, H.; Wie, H.; Jørgensen, R.B.; Ruyter, I.E. Hydroxyapatite coatings on Ti produced by hot isostatic pressing. J. Biomed. Mater. Res. 1994, 28, 343–348. [Google Scholar] [CrossRef] [PubMed]
Nelea, V.; Ristoscu, C.; Chiritescu, C.; Ghica, C.; Mihailescu, I.N.; Pelletier, H.; Mille, P.; Cornet, A. Pulsed laser deposition of hydroxyapatite thin films on Ti-5Al-2.5Fe substrates with and without buffer layers. Appl. Surf. Sci. 2000, 168, 127–131. [Google Scholar] [CrossRef]
Sun, L.; Berndt, C.C.; Gross, K.A.; Kucuk, A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: A review. J. Biomed. Mater. Res. 2001, 58, 570–592. [Google Scholar] [CrossRef] [PubMed]
Lima, R.S.; Khor, K.A.; Li, H.; Cheang, P.; Marple, B.R. HVOF spraying of nanostructured hydroxyapatite for biomedical applications. Mater. Sci. Eng. A 2005, 396, 181–187. [Google Scholar] [CrossRef]
Maitz, M.F.; Pham, M.T.; Matz, W.; Reuther, H.; Steiner, G.; Richter, E. Ion beam treatment of titanium surfaces for enhancing deposition of hydroxyapatite from solution. Biomol. Eng. 2002, 19, 269–272. [Google Scholar] [CrossRef] [PubMed]
Eisenbarth, E.; Velten, D.; Breme, J. Biomimetic implant coatings. Biomol. Eng. 2007, 24, 27–32. [Google Scholar] [CrossRef] [PubMed]
Zhu, L.; Ye, X.; Tang, G.; Zhao, N.; Gong, Y.; Zhao, Y.; Zhao, J.; Zhang, X. Biomimetic coating of compound titania and hydroxyapatite on titanium. J. Biomed. Mater. Res. A 2007, 83, 1165–1175. [Google Scholar] [CrossRef] [PubMed]
Duran, A.; Conde, A.; Coedo, A.G.; Dorado, T.; Garcia, C.; Cere, S. Sol-gel coatings for protection and bioactivation of metals used in orthopaedic devices. J. Mater. Chem. 2004, 14, 2282–2290. [Google Scholar] [CrossRef]
Gupta, R.; Kumar, A. Bioactive materials for biomedical applications using sol-gel technology. Biomed. Mater. 2008, 3. [Google Scholar] [CrossRef]
Yang, Y.; Kim, K.H.; Ong, J.L. A review on calcium phosphate coatings produced using a sputtering process-an alternative to plasma spraying. Biomaterials 2005, 26, 327–337. [Google Scholar] [CrossRef] [PubMed]
Groot, K.; Geesink, R.; Klein, C.; Serekian, P. Plasma sprayed coatings of hydroxyapatite. J. Biomed. Mater. Res. 1987, 21, 1375–1381. [Google Scholar] [CrossRef] [PubMed]
Furlong, R.J.; Osborn, J.F. Fixation of hip prostheses by hydroxyapatite ceramic coatings. J. Bone Joint Surg. Br. 1991, 73, 741–745. [Google Scholar] [PubMed]
Yang, C.Y.; Wang, B.C.; Chang, E.; Wu, J.D. The influences of plasma spraying parameters on the characteristics of hydroxyapatite coatings: a quantitative study. J. Mater. Sci.: Mater. Med. 1995, 6, 249–257. [Google Scholar] [CrossRef]
Montanaro, L.; Arciola, C.R.; Campoccia, D.; Cervellati, M. In vitro effects on MG63 osteoblast-like cells following contact with two roughness-differing fluorohydroxyapatite-coated titanium alloys. Biomaterials 2002, 23, 3651–3659. [Google Scholar] [CrossRef] [PubMed]
Deligianni, D.D.; Katsala, N.D.; Koutsoukos, P.G.; Missirlis, Y.F. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 2001, 22, 87–96. [Google Scholar] [CrossRef] [PubMed]
Boyan, B.D.; Hummert, T.W.; Dean, D.D.; Schwartz, Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 1996, 17, 137–146. [Google Scholar] [CrossRef] [PubMed]
Weng, J.; Liu, Q.; Wolke, J.; Zhang, D.; De Groot, K. The role of amorphous phase in nucleating bone-like apatite on plasma-sprayed hydroxyapatite coatings in simulated body fluid. J. Mater. Sci. Lett. 1997, 16, 335–337. [Google Scholar] [CrossRef]
Zheng, X.; Huang, M.; Ding, C. Bond strength of plasma-sprayed hydroxyapatite/Ti composite coatings. Biomaterials 2000, 21, 841–849. [Google Scholar] [CrossRef] [PubMed]
Nie, X.; Leyland, A.; Matthews, A. Deposition of layered bioceramic hydroxyapatite/TiO2 coatings on titanium alloys using a hybrid technique of micro-arc oxidation and electrophoresis. Surf. Coat. Tech. 2000, 125, 407–414. [Google Scholar] [CrossRef]
Lee, S.H.; Kim, H.W.; Lee, E.J.; Li, L.H.; Kim, H.E. Hydroxyapatite-TiO₂ Hybrid Coating on Ti Implants. J. Biomater. Appl. 2006, 20, 195–208. [Google Scholar] [CrossRef] [PubMed]
He, L.P.; Mai, Y.W.; Chen, Z.Z. Fabrication and characterization of nanometer CaP(aggregate)/Al₂O₃ composite coating on titanium. Mater. Sci. Eng. A 2004, 367, 51–56. [Google Scholar] [CrossRef]
Gautier, S.; Champion, E.; Bernache-Assollant, D. Processing, microstructure and toughness of Al₂O₃ platelet-reinforced hydroxyapatite. J. Eur. Ceram. Soc. 1997, 17, 1361–1369. [Google Scholar] [CrossRef]
Singh, D.; de la Cinta Lorenzo-Martin, M.; Gutiérrez-Mora, F.; Routbort, J.L.; Case, E.D. Self-joining of zirconia/hydroxyapatite composites using plastic deformation process. Acta Biomater. 2006, 2, 669–675. [Google Scholar] [CrossRef] [PubMed]
Inuzuka, M.; Nakamura, S.; Kishi, S.; Yoshida, K.; Hashimoto, K.; Toda, Y.; Yamashita, K. Hydroxyapatite-doped zirconia for preparation of biomedical composites ceramics. Solid State Ionics 2004, 172, 509–513. [Google Scholar] [CrossRef]
Tercero, J.E.; Namin, S.; Lahiri, D.; Balani, K.; Tsoukias, N.; Agarwal, A. Effect of carbon nanotube and aluminum oxide addition on plasma-sprayed hydroxyapatite coating's mechanical properties and biocompatibility. Mater. Sci. Eng. C 2009, 29, 2195–2202. [Google Scholar] [CrossRef]
Shokuhfar, T.; Makradi, A.; Titus, E.; Cabral, G.; Ahzi, S.; Sousa, A.C.M.; Belouettar, S.; Gracio, J. Prediction of the mechanical properties of hydroxyapatite/polymethyl methacrylate/carbon nanotubes nanocomposite. J. Nanosci. Nanotechnol. 2008, 8, 4279–4284. [Google Scholar] [CrossRef] [PubMed]
Balani, K.; Anderson, R.; Laha, T.; Andara, M.; Tercero, J.; Crumpler, E.; Agarwal, A. Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts In vitro. Biomaterials 2007, 28, 618–624. [Google Scholar] [CrossRef] [PubMed]
Leon, B.; Jansen, J.A. Thin Calcium Phosphate Coatings for Biomedical Implants; Springer: Pennsville, NJ, USA, 2009. [Google Scholar]
Bao, Q.H.; Chen, C.Z.; Wang, D.G.; Li, Q.M.; Lei, T.Q. Pulsed laser deposition and its current research status in preparing hydroxyapatite thin films. Appl. Surf. Sci. 2005, 252, 1538–1544. [Google Scholar] [CrossRef]
Koch, C.F.; Johnson, S.; Kumar, D.; Jelinek, M.; Chrisey, D.B.; Doraiswamy, A.; Jin, C.; Narayan, R.J.; Mihailescu, I.N. Pulsed laser deposition of hydroxyapatite thin films. Mater. Sci. Eng. C 2007, 27, 484–494. [Google Scholar] [CrossRef]
Torrisi, L. Structural investigations on laser deposited hydroxyapatite films. Thin Solid Films 1994, 237, 12–15. [Google Scholar] [CrossRef]
Torrisi, L.; Steola, R. Thermally assisted hydroxyapatite obtained by pulsed-laser deposition on titanium substrates. Thin Solid Films 1993, 227, 32–36. [Google Scholar] [CrossRef]
Singh, R.K.; Qian, F.; Nagabushnam, V.; Damodaran, R.; Moudgil, B.M. Excimer laser deposition of hydroxypaptite thin films. Biomaterials 1994, 15, 522–528. [Google Scholar] [CrossRef] [PubMed]
Fernández-Pradas, J.M.; Sardin, G.; Clèries, L.; Serra, P.; Ferrater, C.; Morenza, J.L. Deposition of hydroxyapatite thin films by excimer laser ablation. Thin Solid Films 1998, 317, 393–396. [Google Scholar] [CrossRef]
Lo, W.J.; Grant, D.M.; Ball, M.D.; Welsh, B.S.; Howdle, S.M.; Antonov, E.N.; Bagratashvili, V.N.; Popov, V.K. Physical, chemical , and biological characterization of pulsed laser deposited and plasma sputtered hydroxyapatite thin films on titanium alloy. J. Biomed. Mater. Res. 2000, 50, 536–545. [Google Scholar] [CrossRef] [PubMed]
Ball, M.D.; Downes, S.; Scotchford, C.A.; Antonov, E.N.; Bagratashvili, V.N.; Popov, V.K.; Lo, W.J.; Grant, D.M.; Howdle, S.M. Osteoblast growth on titanium foils coated with hydroxyapatite by pulsed laser ablation. Biomaterials 2001, 22, 337–347. [Google Scholar] [CrossRef] [PubMed]
Fernández-Parada, J.M.; Sardin, G.; Clèries, L.; Serra, P.; Ferrater, C.; Morenza, J.L. Depostion of hydroxyapatite thin films by excimer laser ablation. Thin Solid Films 1998, 317, 393–396. [Google Scholar] [CrossRef]
Feddes, B.; Vredenberg, A.M.; Wehner, M.; Wolke, J.C.G.; Jansen, J.A. Laser-induced crystallization of calcium phosphate coatings on polyethylene (PE). Biomaterials 2005, 26, 1645–1652. [Google Scholar] [CrossRef] [PubMed]
Serra, P.; Morenza, J.L. Evidence of chemical reactions in the hydroxyapatite laser ablation plume with a water atmosphere. J. Appl. Phys. 1999, 85, 3289–3293. [Google Scholar] [CrossRef]
Serra, P.; Clèries, L.; Morenza, J.L. Analysis of the expansion of hydroxyapatite laser ablation plumes. Appl. Surf. Sci. 1996, 96-98, 216–221. [Google Scholar]
Ong, J.L.; Lucas, L.C.; Lacefield, W.R.; Rigney, E.D. Strength of thin calcium phosphate coatings produced by ion beam sputter deposition. Biomaterials 1992, 13, 249–254. [Google Scholar] [CrossRef] [PubMed]
Zeng, H.T.; Chittur, K.K.; Lacefield, W.R. Dissolution/reprecipitation of calcium phosphate thin films produced by ion beam sputter deposition technique. Biomaterials 1999, 20, 443–451. [Google Scholar] [CrossRef] [PubMed]
Cui, F.Z.; Luo, Z.S.; Feng, Q.L. Highly adhesive hydroxyapatite coatings on titanium alloy formed by ion beam assisted deposition. J. Mater. Sci.: Mater. Med. 1997, 8, 403–405. [Google Scholar] [CrossRef]
Ong, J.L.; Lucas, L.C. Post-deposition heat treatments for ion beam sputter deposited calcium phosphate coatings. Biomaterials 1994, 15, 337–341. [Google Scholar] [CrossRef] [PubMed]
Hamdi, M.; Ide-Ektessabi, A. Preparation of hydroxyapatite layer by ion beam assisted simultaneous vapor deposition. Surf. Coat. Technol. 2003, 163-164, 362–367. [Google Scholar]
Lee, I.-S.; Whang, C.N.; Lee, G.H.; Cui, F.Z.; Ito, A. Effects of ion beam assist on the formation of calcium phosphate films. Nucl. Instrum. Meth. Phys. Res. B 2003, 206, 522–526. [Google Scholar] [CrossRef]
Yoshinari, M.; Ohtsuka, Y.; Dérand, T. Thin hydroxyapatite coating produced by the ion beam dynamic mixing method. Biomaterials 1994, 15, 529–535. [Google Scholar] [CrossRef] [PubMed]
Cui, F.Z.; Luo, Z.S. Biomaterials modification by ion-beam processing. Surf. Coat. Technol. 1999, 112, 278–285. [Google Scholar] [CrossRef]
Yoshinari, M.; Klinge, B.; Dérand, T. The biocompatibility (cell culture and histological study) of hydroxy-apatite-coated implants created by ion beam dynamic mixing. Clin. Oral Impl. Res. 1996, 7, 96–100. [Google Scholar] [CrossRef]
Yoshinari, M.; Ohtsuka, Y.; Dérand, T. Thin hydroxyapatite coatings produced by ion beam dynamic mixing method. Biomaterials 1994, 15, 529–535. [Google Scholar] [CrossRef] [PubMed]
Ohtsuka, Y.; Matsuura, M.; Chida, N. Formation of hydroxyapatite coatings on pure titanium substrates by ion beam dynamic mixing. Surf. Coat. Technol. 1994, 65, 224–230. [Google Scholar] [CrossRef]
Lee, I.S.; Kim, D.H.; Kim, H.E.; Jung, Y.C.; Han, C.H. Biological performance of calcium phosphate films formed on commercially pure Ti by electron-beam evaporation. Biomaterials 2002, 23, 609–615. [Google Scholar] [CrossRef] [PubMed]
Ozeki, K.; Yuhta, T.; Fukui, Y. A functionally graded titanium/hydroxyapatite film obtained by sputtering. J. Mater. Sci.: Mater. Med. 2002, 13, 253–258. [Google Scholar] [CrossRef]
Nelea, V.; Morosanu, C.; Iliescu, M. Mihailescu. Microstructure and mechnical properties of hydroxyapatite thin films grown by RF magnetron sputtering. Surf. Coat. Technol. 2003, 173, 315–322. [Google Scholar] [CrossRef]
Ding, S.J.; Ju, C.P.; Chern Lin, J.H. Immersion behavior of RF magnetron-assisted sputtered hydroxyapatite/titanium coatings in simulated body fluid. J. Biomed. Mater. Res. 1999, 47, 551–563. [Google Scholar] [CrossRef] [PubMed]
Nelea, V.; Morosanu, C.; Iliescu, M.; Mihailescu, I.N. Hydroxyapatite thin films grown by pulsed laser depostion and radio-frequency magnetron sputtering: comparative study. Appl. Surf. Sci. 2004, 228, 346–356. [Google Scholar] [CrossRef]
Jansen, J.A.; Wolke, J.G.C.; Swann, S.; van der Waerden, J.P.C.M.; de Groot, K. Application of magnetron sputtering for producing ceramic coatings on implant materials. Clin. Oral. Impl. Res. 1993, 4, 28–34. [Google Scholar] [CrossRef]
Wie, H.; Hero, H.; Solheim, T. Hot isostatic pressing-processed hydroxyapatite-coated titanium implants: light microscopic and scanning electron microscopy investigations. Int. J. Oral. Maxillofac. Implants 1998, 13, 837–844. [Google Scholar] [PubMed]
Habibovic, P.; Barrere, F.; Blitterswijk van, C.A.; Groot de, K. Biomimetic hydroxyapatite coating on metal implants. J. Am. Ceram. Soc. 2002, 85, 517–522. [Google Scholar] [CrossRef]
Forsgren, J.; Svahn, F.; Jarmar, T.; Engqvist, H. Formation and adhesion of biomimetic hydroxyapatite deposited on titanium substrates. Acta Biomater. 2007, 3, 980–984. [Google Scholar] [CrossRef] [PubMed]
Liu, D.M.; Yang, Q.Z.; Troczynski, T. Sol-gel hydroxyapatite coatings on stainless steel substrates. Biomaterials 2002, 23, 691–698. [Google Scholar] [CrossRef]
Kim, H.W.; Kim, H.E.; Knowles, J.C. Fluor-hydroxyapatite sol-gel coatings on titanium substrate for hard tissue implants. Biomaterials 2004, 25, 3351–3358. [Google Scholar] [CrossRef] [PubMed]
Balani, K.; Chen, Y.; Harimkar, S.P.; Dahotre, N.B.; Agarwal, A. Tribological behavior of plasma-sprayed carbon nanotube-reinforced hydroxyapatite coating in physiological solution. Acta Biomater. 2007, 3, 944–951. [Google Scholar] [CrossRef] [PubMed]
Hench, L.; Anderson, O. Bioactive glass. In An Introduction to Bioceramics; Hench, L., Wilson, L., Eds.; World Scientific: Pennsville, NJ, USA, 1993; p. 41. [Google Scholar]
Bolelli, G.; Cannillo, V.; Gadow, R.; Killinger, A.; Lusvarghi, L.; Rauch, J. Microstructural and In vitro characterisation of high-velocity suspension flame sprayed (HVSFS) bioactive glass coatings. J. Eur. Ceram. Soc. 2009, 29, 2249–2257. [Google Scholar] [CrossRef]
Xynos, I.D.; Edgar, A.J.; Buttery, L.D.K.; Hench, L.L.; Polak, J.M. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J. Biomed. Mater. Res. 2001, 55, 151–157. [Google Scholar] [CrossRef] [PubMed]
Christodoulou, I.; Buttery, L.D.K.; Tai, G.; Hench, L.L.; Polak, J.M. Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J. Biomed. Mater. Res. B Appl. Biomater. 2006, 77, 431–446. [Google Scholar] [CrossRef] [PubMed]
Oliva, A.; Salerno, A.; Locardi, B.; Riccio, V.; Della Ragione, F.; Iardino, P.; Zappia, V. Behaviour of human osteoblasts cultured on bioactive glass coatings. Biomaterials 1998, 19, 1019–1025. [Google Scholar] [CrossRef] [PubMed]
Fathi, M.H.; Doost Mohammadi, A. Preparation and characterization of sol-gel bioactive glass coating for improvement of biocompatibility of human body implant. Mater. Sci. Eng. A 2008, 474, 128–133. [Google Scholar] [CrossRef]
Foppiano, S.; Marshall, S.J.; Marshall, G.W.; Saiz, E.; Tomsia, A.P. Bioactive glass coatings affect the behavior of osteoblast-like cells. Acta Biomater. 2007, 3, 765–771. [Google Scholar] [CrossRef] [PubMed]
Zhitomirsky, D.; Roether, J.A.; Boccaccini, A.R.; Zhitomirsky, I. Electrophoretic deposition of bioactive glass/polymer composite coatings with and without HA nanoparticle inclusions for biomedical applications. J. Mater. Process. Technol. 2009, 209, 1853–1860. [Google Scholar] [CrossRef]
Wang, C.X.; Chen, Z.Q.; Wang, M. Fabrication and characterization of bioactive glass coatings produced by the ion beam sputter deposition technique. J. Mater. Sci. Mater. Med. 2002, 13, 247–251. [Google Scholar] [CrossRef]
Comesaña, R.; Quintero, F.; Lusquiños, F.; Pascual, M.J.; Boutinguiza, M.; Durán, A.; Pou, J. Laser cladding of bioactive glass coatings. Acta Biomater. 2010, 6, 953–961. [Google Scholar] [CrossRef] [PubMed]
D'Alessio, L.; Teghil, R.; Zaccagnino, M.; Zaccardo, I.; Ferro, D.; Marotta, V. Pulsed laser ablation and deposition of bioactive glass as coating material for biomedical applications. Appl. Surf. Sci. 1999, 138, 527–532. [Google Scholar] [CrossRef]
Chern Lin, J.H.; Liu, M.L.; Ju, C.P. Structure and properties of hydroxyapatite-bioactive glass composites plasma sprayed on Ti6Al4V. J. Mater. Sci. Mater. Med. 1994, 5, 279–283. [Google Scholar] [CrossRef]
Gomez-Vega, J.M.; Saiz, E.; Tomsia, A.P. Glass-based coatings for titanium implant alloys. J. Biomed. Mater. Res. 1999, 46, 549–559. [Google Scholar] [CrossRef] [PubMed]
Gallardo, J.; Galliano, P.; Durán, A. Bioactive and protective sol-gel coatings on metals for orthopaedic prostheses. J. Sol-Gel Sci. Technol. 2001, 21, 65–74. [Google Scholar] [CrossRef]
Liu, X.; Morra, M.; Carpi, A.; Li, B. Bioactive calcium silicate ceramics and coatings. Biomed. Pharmacother. 2008, 62, 526–529. [Google Scholar] [CrossRef] [PubMed]
Liu, X.Y.; Ding, C.X.; Wang, Z.Y. Apatite formed on the surface of plasma-sprayed wollastonite coating immersed in simulated body fluid. Biomaterials 2001, 22, 2007–2012. [Google Scholar] [CrossRef] [PubMed]
Liu, X.Y.; Ding, C.X. Phase compositions and microstructure of plasma sprayed wollastonite coating. Surf. Coat. Tech. 2001, 141, 269–274. [Google Scholar] [CrossRef]
Liu, X.Y.; Xie, Y.T.; Ding, C.X.; Chu, P.K. Early apatite deposition and osteoblast growth on plasma-sprayed dicalcium silicate coating. J. Biomed. Mater. Res. A 2005, 74A, 356–365. [Google Scholar] [CrossRef] [PubMed]
Xue, W.C.; Liu, X.Y.; Zheng, X.B.; Ding, C.X. Plasma-sprayed diopside coatings for biomedical applications. Surf. Coat. Tech. 2004, 185, 340–345. [Google Scholar] [CrossRef]
Liu, X.Y.; Tao, S.Y.; Ding, C.X. Bioactivity of plasma sprayed dicalcium silicate coatings. Biomaterials 2002, 23, 963–968. [Google Scholar] [CrossRef] [PubMed]
Liu, X.Y.; Ding, C.X.; Chu, P.K. Mechanism of apatite formation on wollastonite coatings in simulated body fluids. Biomaterials 2004, 25, 1755–1761. [Google Scholar] [CrossRef] [PubMed]
Xie, Y.T.; Liu, X.Y.; Ding, C.X.; Chu, P.K. Bioconductivity and mechanical properties of plasma-sprayed dicalcium silicate/zirconia composite coating. Mater. Sci. Eng. C 2005, 25, 509–515. [Google Scholar] [CrossRef]
Liu, X.Y.; Ding, C.X. Plasma-sprayed wollastonite 2M/ZrO₂ composite coating. Surf. Coat. Tech. 2003, 172, 270–278. [Google Scholar] [CrossRef]
Sun, J.; Li, J.; Liu, X.; Wei, L.; Wang, G.; Meng, F. Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. Biomed. Pharmacother. 2009, 63, 650–657. [Google Scholar] [CrossRef] [PubMed]
Wu, C.T.; Ramaswamy, Y.; Chang, J.; Woods, J.; Chen, Y.Q.; Zreiqat, H. The effect of Zn contents on phase composition, chemical stability and cellular bioactivity in Zn-Ca-Si system ceramics. J. Biomed. Mater. Res.: Appl. Biomater. 2008, 87B, 346–353. [Google Scholar] [CrossRef]
Wu, C.T.; Ramaswamy, Y.; Kwik, D.; Zreiqat, H. The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties. Biomaterials 2007, 28, 3171–3181. [Google Scholar] [CrossRef] [PubMed]
Ramaswamy, Y.; Wu, C.T.; Hummel, A.V.; Combes, V.; George, G.; Zreiqat, H. The responses of osteoblast, osteoclast and endothelial cells to zirconium modified calcium-silicate-based ceramic. Biomaterials 2008, 29, 4392–4402. [Google Scholar] [CrossRef] [PubMed]
Kuromoto, N.K.; Simão, R.A.; Soares, G.A. Titanium oxide films produced on commercially pure titanium by anodic oxidation with different voltages. Mater. Chara. 2007, 58, 114–121. [Google Scholar] [CrossRef]
Yang, B.; Uchida, M.; Kim, H.M.; Zhang, X.; Kokubo, T. Preparation of bioactive titanium metal via anodic oxidation treatment. Biomaterials 2004, 25, 1003–1010. [Google Scholar] [CrossRef] [PubMed]
Advincula, M.C.; Rahemtulla, F.G.; Advincula, R.C.; Ada, E.T.; Lemons, J.E.; Bellis, S.L. Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide. Biomaterials 2006, 27, 2201–2212. [Google Scholar] [CrossRef] [PubMed]
Wang, G.; Meng, F.; Ding, C.; Chu, P.K.; Liu, X. Microstructure, bioactivity and osteoblast behavior of monoclinic zirconia coating with nanostructured surface. Acta Biomater. 2010, 6, 990–1000. [Google Scholar] [CrossRef] [PubMed]
Sollazzo, V.; Palmieri, A.; Pezzetti, F.; Bignozzi, C.A.; Argazzi, R.; Massari, L.; Brunelli, G.; Carinci, F. Genetic effect of zirconium oxide coating on osteoblast-like cells. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 84, 550–558. [Google Scholar] [CrossRef] [PubMed]
Han, Y.; Chen, D.; Sun, J.; Zhang, Y.; Xu, K. UV-enhanced bioactivity and cell response of micro-arc oxidized titania coatings. Acta Biomater. 2008, 4, 1518–1529. [Google Scholar] [CrossRef] [PubMed]
Li, P.; Ohtsuki, C.; Kokubo, T.; Nakanishi, K.; Soga, N.; Groot, K.d. The role of hydrated silica, titania, and alumina in inducing apatite on implants. J. Biomed. Mater. Res. 1994, 28, 7–15. [Google Scholar] [CrossRef] [PubMed]
Uchida, M.; Kim, H.M.; Kokubo, T.; Fujibayashi, S.; Nakamura, T. Structural dependence of apatite formation on titania gels in a simulated body fluid. J. Biomed. Mater. Res. A 2003, 64, 164–170. [Google Scholar] [CrossRef] [PubMed]
Wang, G.; Liu, X.; Ding, C. Phase composition and in vitro bioactivity of plasma sprayed calcia stabilized zirconia coatings. Surf. Coat. Tech. 2008, 202, 5824–5831. [Google Scholar] [CrossRef]
Yan, Y.; Han, Y.; Lu, C. The effect of chemical treatment on apatite-forming ability of the macroporous zirconia films formed by micro-arc oxidation. Appl. Surf. Sci. 2008, 254, 4833–4839. [Google Scholar] [CrossRef]
Han, Y.; Yan, Y.; Lu, C. Ultraviolet-enhanced bioactivity of ZrO₂ films prepared by micro-arc oxidation. Thin Solid Films 2009, 517, 1577–81. [Google Scholar] [CrossRef]
Yan, Y.; Han, Y. Structure and bioactivity of micro-arc oxidized zirconia films. Surf. Coat. Tech. 2007, 201, 5692–5695. [Google Scholar] [CrossRef]
Liu, X.; Zhao, X.; Li, B.; Cao, C.; Dong, Y.; Ding, C.; Chu, P.K. UV-irradiation-induced bioactivity on TiO₂ coatings with nanostructural surface. Acta Biomater. 2008, 4, 544–552. [Google Scholar] [CrossRef] [PubMed]
Bishop, A.; Balázsi, C.; Yang, J.H.C.; Gouma, P.I. Biopolymer-hydroxyapatite composite coatings prepared by electrospinning. Polym. Adv. Technol. 2006, 17, 902–906. [Google Scholar] [CrossRef]
Bigi, A.; Panzavolta, S.; Roveri, N. Hydroxyapatite-gelatin films: a structural and mechanical characterization. Biomaterials 1998, 19, 739–744. [Google Scholar] [CrossRef] [PubMed]
Kino, R.; Ikoma, T.; Yunoki, S.; Nagai, N.; Tanaka, J.; Asakura, T.; Munekata, M. Preparation and characterization of multilayered hydroxyapatite/silk fibroin film. J. Biosci. Bioeng. 2007, 103, 514–520. [Google Scholar] [CrossRef] [PubMed]
Wahl, D.A.; Czernuszka, C.J. Collagen-hydroxyapatite composites for hard tissue repair. Eur. Cell Mater. 2006, 11, 43–56. [Google Scholar] [PubMed]
Sato, M.; Slamovich, E.B.; Webster, T.J. Enhanced osteoblast adhesion on hydrothermally treated hydroxyapatite/titania/poly(lactide-co-glycolide) sol-gel titanium coatings. Biomaterials 2005, 26, 1349–1357. [Google Scholar] [CrossRef] [PubMed]
Chen, D.; Jordan, E.H.; Gell, M.; Wei, M. Apatite formation on alkaline-treated dense TiO₂ coatings deposited using the solution precursor plasma spray process. Acta Biomater. 2008, 4, 553–559. [Google Scholar] [CrossRef] [PubMed]
Jokinen, M.; Pätsi, M.; Rahiala, H.; Peltola, T.; Ritala, M.; Rosenholm, J.B. Influence of sol and surface properties on In vitro bioactivity of sol-gel-derived TiO₂ and TiO₂-SiO₂ films deposited by dip-coating method. J. Biomed. Mater. Res. 1998, 42, 295–302. [Google Scholar] [CrossRef] [PubMed]
Liu, X.; Zhao, X.; Fu, R.K.Y.; Ho, J.P.Y.; Ding, C.; Chu, P.K. Plasma-treated nanostructured TiO₂ surface supporting biomimetic growth of apatite. Biomaterials 2005, 26, 6143–6150. [Google Scholar] [CrossRef] [PubMed]
Lin, C.M.; Yen, S.K. Biomimetic growth of apatite on electrolytic TiO₂ coatings in simulated body fluid. Mater. Sci. Eng. C 2006, 26, 54–64. [Google Scholar] [CrossRef]
Cui, X.; Kim, H.M.; Kawashita, M.; Wang, L.; Xiong, T.; Kokubo, T.; Nakamura, T. Preparation of bioactive titania films on titanium metal via anodic oxidation. Dental Mater. 2009, 25, 80–86. [Google Scholar] [CrossRef]
Liu, X.; Huang, A.; Ding, C.; Chu, P.K. Bioactivity and cytocompatibility of zirconia (ZrO₂) films fabricated by cathodic arc deposition. Biomaterials 2006, 27, 3904–3911. [Google Scholar] [CrossRef] [PubMed]
Park, Y.J.; Kim, K.H.; Lee, J.Y.; Ku, Y.; Lee, S.J.; Min, B.M.; Chung, C.P. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol. Appl. Biochem. 2006, 43, 17–24. [Google Scholar] [CrossRef] [PubMed]
Schliephak, H.; Scharnweber, D. Chemical and biological functionalization of titanium for dental implants. J. Mater. Chem. 2008, 18, 2404–2414. [Google Scholar] [CrossRef]
Adden, N.; Gamble, L.J.; Castner, D.G.; Hoffman, A.; Gross, G.; Menzel, H. Phosphonic Acid monolayers for binding of bioactive molecules to titanium surfaces. Langmuir 2006, 22, 8197–8204. [Google Scholar] [CrossRef] [PubMed]
Tebbe, D.; Thull, R.; Gbureck, U. Influence of spacer length on heparin coupling efficiency and fibrinogen adsorption of modified titanium surfaces. Biomed. Eng. Online 2007, 6. [Google Scholar] [CrossRef]
Nanci, A.; Wuest, J.D.; Peru, L.; Brunet, P.; Sharma, V.; Zalzal, S.; McKee, M.D. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J. Biomed. Mater. Res. 1998, 40, 324–335. [Google Scholar] [CrossRef] [PubMed]
Siow, K.S.; Britcher, L.; Kumar, S.; Griesser, H.J. Plasma Methods for the generation of chemically reactive surfaces for biomolecule immobilization and cell colonization—A review. Plasma Process. Polym. 2006, 3, 392–418. [Google Scholar] [CrossRef]
Chatelier, R.C.; Xie, X.; Gengenbach, T.R.; Griesser, H.J. Effects of plasma modification conditions on surface restructuring. Langmuir 1995, 11, 2585–2591. [Google Scholar] [CrossRef]
Meyer-Plath, A.A.; Finke, B.; Schröder, K.; Ohl, A. Pulsed and cw microwave plasma excitation for surface functionalization in nitrogen-containing gases. Surf. Coat. Tech. 174-175, 877–881.
Gancarz, I.; Bryjak, J.; Bryjak, M.; Pozniak, G.; Tylus, W. Plasma modified polymers as a support for enzyme immobilization 1.: Allyl alcohol plasma. Eur. Polym. J. 2003, 39, 1615–1622. [Google Scholar] [CrossRef]
Swaraj, S.; Oran, U.; Lippitz, A.; Friedrich, J.F.; Unger, W.E.S. Study of influence of external plasma parameters on plasma polymerised films prepared from organic molecules (acrylic acid, allyl alcohol, allyl amine) using XPS and NEXAFS. Surf. Coat. Tech. 2005, 200, 494–497. [Google Scholar] [CrossRef]
Puleo, D.A.; Kissling, R.A.; Sheu, M.S. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002, 23, 2079–2087. [Google Scholar] [CrossRef] [PubMed]
Herr, G.; Hartwig, C.H.; Boll, C.; Küsswetter, W. Ectopic bone formation by composites of BMP and metal implants in rats. Acta Orthop. 1996, 67, 606–610. [Google Scholar] [CrossRef]
Seol, Y.J.; Park, Y.J.; Lee, S.C.; Kim, K.H.; Lee, J.Y.; Kim, T.I.; Lee, Y.M.; Ku, Y.; Rhyu, I.C.; Han, S.B.; Chung, C.P. Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2. J. Biomed. Mater. Res. A 2006, 77A, 599–607. [Google Scholar] [CrossRef] [PubMed]
Länge, K.; Herold, M.; Scheideler, L.; Geis-Gerstorfer, J.; Wendel, H.P.; Gauglitz, G. Investigation of initial pellicle formation on modified titanium dioxide (TiO₂) surfaces by reflectometric interference spectroscopy (RIfS) in a model system. Dent. Mater. 2004, 20, 814–822. [Google Scholar] [CrossRef] [PubMed]
Yoshinari, M.; Oda, Y.; Kato, T.; Okuda, K. Influence of surface modifications to titanium on antibacterial activity In vitro. Biomaterials 2001, 22, 2043–2048. [Google Scholar] [CrossRef] [PubMed]
Wikesjö, U.M.E.; Qahash, M.; Thomson, R.C.; Cook, A.D.; Rohrer, M.D.; Wozney, J.M.; Hardwick, W.R. rhBMP-2 significantly enhances guided bone regeneration. Clinl. Oral Implants Res. 2004, 15, 194–204. [Google Scholar] [CrossRef]
Schmidmaier, G.; Wildemann, B.; Cromme, F.; Kandziora, F.; Haas, N.P.; Raschke, M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone 2002, 30, 816–822. [Google Scholar] [CrossRef] [PubMed]
Schmidmaier, G.; Wildemann, B.; Bail, H.; Lucke, M.; Fuchs, T.; Stemberger, A.; Flyvbjerg, A.; Haas, N.P.; Raschke, M. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-[beta, #2799]1) from a biodegradable poly(-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 2001, 28, 341–350. [Google Scholar] [CrossRef] [PubMed]
Puleo, D.A. Release and Retention of Biomolecules in Collagen Deposited on Orthopedic. Biomaterials 1999, 27, 65–75. [Google Scholar]
Agrawal, C.M.; Pennick, A.; Wang, X.; Schenck, R.C. Porous-coated titanium implant impregnated with a biodegradable protein delivery system. J. Biomed. Mater. Res. 1997, 36, 516–521. [Google Scholar] [CrossRef] [PubMed]
Welsh, W.R.; Kim, H.D.; Jong, Y.S.; Valentini, R.F. Controlled release of platelet-derived growth factor using ethylene vinyl acetate copolymer (EVAc) coated on stainless-steel wires. Biomaterials 1995, 16, 1319–1325. [Google Scholar] [CrossRef] [PubMed]
Hubbell, J.A. Bioactive biomaterials. Curr. Opin. Biotechnol. 1999, 10, 123–129. [Google Scholar] [CrossRef] [PubMed]
Castner, D.G.; Ratner, B.D. Biomedical surface science: Foundations to frontiers. Surf. Sci. 2002, 500, 28–60. [Google Scholar] [CrossRef]
Darouiche, R.O. Treatment of Infections Associated with Surgical Implants. N. Engl. J. Med. 2004, 350, 1422–1429. [Google Scholar] [CrossRef] [PubMed]
Tunney, M.M.; Patrick, S.; Curran, M.D.; Ramage, G.; Hanna, D.; Nixon, J.R.; Gorman, S.P.; Davis, R.I.; Anderson, N. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and pcr amplification of the bacterial 16S rRNA gene. J. Clin. Microbiol. 1999, 37, 3281–3290. [Google Scholar] [PubMed]
Hetrick, E.M.; Prichard, H.L.; Klitzman, B.; Schoenfisch, M.H. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 2007, 28, 4571–4580. [Google Scholar] [CrossRef] [PubMed]
Grainger, D.W. Controlled-release and local delivery of therapeutic antibodies. Expert Opin. Biol. Ther. 2004, 4, 1029–1044. [Google Scholar] [CrossRef] [PubMed]
Lee, D.; Cohen, R.E.; Rubner, M.F. Antibacterial properties of ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir 2005, 21, 9651–9659. [Google Scholar] [CrossRef] [PubMed]
Schreurs, W.J.; Rosenberg, H. Effect of silver ions on transport and retention of phosphate by Escherichia coli. J. Bacteriol. 1982, 152, 7–13. [Google Scholar] [PubMed]
Holt, K.B.; Bard, A.J. Interaction of Silver(I) Ions with the Respiratory Chain of Escherichia coli: An Electrochemical and Scanning Electrochemical Microscopy Study of the Antimicrobial Mechanism of Micromolar Ag⁺. Biochemistry 2005, 44, 13214–13223. [Google Scholar] [CrossRef] [PubMed]
Ghandour, W.; Hubbard, J.A.; Deistung, J.; Hughes, M.N.; Poole, R.K. The uptake of silver ions by Escherichia coli K12: toxic effects and interaction with copper ions. Appl. Microbiol. Biotechnol. 1988, 28, 559–565. [Google Scholar]
Zeiri, L.; Bronk, B.V.; Shabtai, Y.; Eichler, J.; Efrima, S. Surface-Enhanced raman spectroscopy as a tool for probing specific biochemical components in bacteria. Appl. Spectrosc. 2004, 58, 33–40. [Google Scholar] [CrossRef] [PubMed]
Jeon, H.J.; Yi, S.C.; Oh, S.G. Preparation and antibacterial effects of Ag-SiO₂ thin films by sol-gel method. Biomaterials 2003, 24, 4921–4928. [Google Scholar] [CrossRef] [PubMed]
Wang, J.; Li, J.X.; Shen, L.R.; Ren, L.; Xu, Z.J.; Zhao, A.S.; Leng, Y.X.; Huang, N. The biomedical properties of polyethylene terephthalate surface modified by silver ion implantation. Nucl. Instrum. Methods Phys. Res. B 2007, 257, 141–145. [Google Scholar] [CrossRef]
Zhao, J.; Cai, X.M.; Tang, H.Q.; Liu, T.; Gu, H.Q.; Cui, R.Z. Bactericidal and biocompatible properties of TiN/Ag multilayered films by ion beam assisted deposition. J. Mater. Sci.: Mater. Med. 2009, 20, 101–105. [Google Scholar] [CrossRef]
Necula, B.S.; Fratila-Apachitei, L.E.; Zaat, S.A.J.; Apachitei, I.; Duszczyk, J. In vitro antibacterial activity of porous TiO₂-Ag composite layers against methicillin-resistant Staphylococcus aureus. Acta Biomater. 2009, 5, 3573–3580. [Google Scholar] [CrossRef] [PubMed]
Galya, T.; Sedlarik, V.; Kuritka, I.; Novotny, R.; Sedlarikova, J.; Saha, P. Antibacterial poly(vinyl alcohol) film containing silver nanoparticles: preparation and characterization. J. Appl. Polym. Sci. 2008, 110, 3178–3185. [Google Scholar] [CrossRef]
Evans, P.; Sheel, D.W. Photoactive and antibacterial TiO₂ thin films on stainless steel. Surf. Coat. Tech. 2007, 201, 9319–9324. [Google Scholar] [CrossRef]
Stobie, N.; Duffy, B.; Hinder, S.J.; McHale, P.; McCormack, D.E. Silver doped perfluoropolyether-urethane coatings: antibacterial activity and surface analysis. Colloids. Surf. B Biointerfaces 2009, 72, 62–67. [Google Scholar] [CrossRef] [PubMed]
Lok, C.N.; Ho, C.M.; Chen, R.; He, Q.Y.; Yu, W.Y.; Sun, H.; Tam, P.; Chiu, J.F.; Che, C.M. Silver nanoparticles: partial oxidation and antibacterial activities. J. Biol. Inorg. Chem. 2007, 12, 527–534. [Google Scholar] [CrossRef] [PubMed]
Pal, S.; Tak, Y.K.; Song, J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? a study of the gram-negative bacterium escherichia coli. Appl. Environ. Microbiol. 2007, 73, 1712–1720. [Google Scholar] [CrossRef] [PubMed]
Wang, J.; Li, J.; Ren, L.; Zhao, A.; Li, P.; Leng, Y.; Sun, H.; Huang, N. Antibacterial activity of silver surface modified polyethylene terephthalate by filtered cathodic vacuum arc method. Surf. Coat. Tech. 2007, 201, 6893–6896. [Google Scholar] [CrossRef]
Yamamoto, O. Influence of particle size on the antibacterial activity of zinc oxide. Int. J. Inorg. Mater. 2001, 3, 643–646. [Google Scholar] [CrossRef]
Zhou, H.; Xu, L.; Ogino, A.; Nagatsu, M. Investigation into the antibacterial property of carbon films. Diam. Relat. Mater. 17, 1416–1419.
Suketa, N.; Sawase, T.; Kitaura, H.; Naito, M.; Baba, K.; Nakayama, K.; Wennerberg, A.; Atsuta, M. An antibacterial surface on dental implants, based on the photocatalytic bactericidal effect. Clin. Implant Dent. Relat. Res. 2005, 7, 105–111. [Google Scholar] [CrossRef] [PubMed]
Marciano, F.R.; Lima-Oliveira, D.A.; Da-Silva, N.S.; Diniz, A.V.; Corat, E.J.; Trava-Airoldi, V.J. Antibacterial activity of DLC films containing TiO₂ nanoparticles. J. Colloid. Interface Sci. 2009, 340, 87–92. [Google Scholar] [CrossRef] [PubMed]
Applerot, G.; Perkas, N.; Amirian, G.; Girshevitz, O.; Gedanken, A. Coating of glass with ZnO via ultrasonic irradiation and a study of its antibacterial properties. Appl. Surf. Sci. 2009, 256S, S3–S8. [Google Scholar] [CrossRef]
Dowling, D.P.; Betts, A.J.; Pope, C.; McConnell, M.L.; Eloy, R.; Arnaud, M.N. Anti-bacterial silver coatings exhibiting enhanced activity through the addition of platinum. Surf. Coat. Tech. 2003, 163-164, 637–640. [Google Scholar] [CrossRef]
Fujishima, A.; Rao, T.N.; Tryk, D.A. Titanium dioxide photocatalysis. J. Photochem Photobiol. C Photochem. Rev. 2000, 1, 1–21. [Google Scholar] [CrossRef]
Maness, P.C.; Smolinski, S.; Blake, D.M.; Huang, Z.; Wolfrum, E.J.; Jacoby, W.A. Bactericidal Activity of Photocatalytic TiO₂ Reaction: toward an Understanding of Its Killing Mechanism. Appl. Environ. Microbiol. 1999, 65, 4094–4098. [Google Scholar] [PubMed]
Kikuchi, Y.; Sunada, K.; Iyoda, T.; Hashimoto, K.; Fujishima, A. Photocatalytic bactericidal effect of TiO₂ thin films: dynamic view of the active oxygen species responsible for the effect. J. Photochem. Photobiol. A Chem. 1997, 106, 51–56. [Google Scholar] [CrossRef]
Marciano, F.R.; Bonetti, L.F.; Santos, L.V.; Da-Silva, N.S.; Corat, E.J.; Trava-Airoldi, V.J. Antibacterial activity of DLC and Ag-DLC films produced by PECVD technique. Diam. Relat. Mater. 2009, 18, 1010–1014. [Google Scholar] [CrossRef]
Boeckh, C.; Schumacher, E.; Podbielski, A.; Haller, B. Antibacterial activity of restorative dental biomaterials in vitro. Caries Res. 2002, 36, 101–107. [Google Scholar] [CrossRef] [PubMed]
Tobias, R.S.; Browne, R.M.; Wilson, C.A. Antibacterial activity of dental restorative materials. Int. Endod. J. 1985, 18, 161–171. [Google Scholar] [CrossRef] [PubMed]
Hirota, K.; Sugimoto, M.; Kato, M.; Tsukagoshi, K.; Tanigawa, T.; Sugimoto, H. Preparation of zinc oxide ceramics with a sustainable antibacterial activity under dark conditions. Ceram. Int. 2010, 36, 497–506. [Google Scholar] [CrossRef]
Yamamoto, O.; Komatsu, M.; Sawai, J.; Nakagawa, Z. Effect of lattice constant of zinc oxide on antibacterial characteristics. J. Mater. Sci.: Mater. Med. 2004, 15, 847–851. [Google Scholar] [CrossRef]
Ohira, T.; Yamamoto, O.; Iida, Y.; Nakagawa, Z. Antibacterial activity of ZnO powder with crystallographic orientation. J. Mater. Sci.: Mater. Med. 2008, 19, 1407–1412. [Google Scholar] [CrossRef]
Sawai, J.; Kawada, E.; Kanou, F.; Igarashi, H.; Hashimoto, A.; Kokugan, T.; Shimizu, M. Detection of active oxygen generated from ceramic powders having antibacterial activity. J. Chem. Eng. Jpn. 1996, 29, 627–633. [Google Scholar] [CrossRef]
Sawai, J.; Shoji, S.; Igarashi, H.; Hashimoto, A.; Kokugan, T.; Shimizu, M.; Kojima, H. Hydrogen peroxide as an antibacterial factor in zinc oxide powder slurry. J. Ferment. Bioeng. 1998, 86, 521–522. [Google Scholar] [CrossRef]
Wu, P.; Grainger, D.W. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006, 27, 2450–2467. [Google Scholar] [CrossRef] [PubMed]
Stigter, M.; Bezemer, J.; de Groot, K.; Layrolle, P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J. Control. Release 2004, 99, 127–137. [Google Scholar] [CrossRef] [PubMed]
Shintani, H. Modification of medical device surface to attain anti-infection. Trends Biomater. Artif. Organs 2004, 18, 1–8. [Google Scholar]
Basak, P.; Adhikari, B.; Banerjee, I.; Maiti, T.K. Sustained release of antibiotic from polyurethane coated implant materials. J. Mater. Sci. Mater. Med. 2009, 20, 213–221. [Google Scholar] [CrossRef]
Schierholz, J.M.; Steinhauser, H.; Rump, A.F.E.; Berkels, R.; Pulverer, G. Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials 1997, 18, 839–844. [Google Scholar] [CrossRef] [PubMed]
Rojas, I.A.; Slunt, J.B.; Grainger, D.W. Polyurethane coatings release bioactive antibodies to reduce bacterial adhesion. J. Control. Release 2000, 63, 175–189. [Google Scholar] [CrossRef] [PubMed]
Poelstra, K.A.; Barekzi, N.A.; Rediske, A.M.; Felts, A.G.; Slunt, J.B. Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies. J. Biomed. Mater. Res. 2002, 60, 206–215. [Google Scholar] [CrossRef] [PubMed]
Stigter, M.; de Groot, K.; Layrolle, P. Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials 2002, 23, 4143–4153. [Google Scholar] [CrossRef] [PubMed]
Radin, S.; Campbell, J.T.; Ducheyne, P.; Cuckler, J.M. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 1997, 18, 777–782. [Google Scholar] [CrossRef] [PubMed]
Alt, V.; Bitschnau, A.; Österling, J.; Sewing, A.; Meyer, C.; Kraus, R.; Meissner, S.A.; Wenisch, S.; Domann, E.; Schnettler, R. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 2006, 27, 4627–4634. [Google Scholar] [CrossRef] [PubMed]
Ignarro, L. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 1990, 16, 477–483. [Google Scholar] [CrossRef] [PubMed]
Nablo, B.J.; Prichard, H.L.; Butler, R.D.; Klitzman, B.; Schoenfisch, M.H. Inhibition of implant-associated infections via nitric oxide release. Biomaterials 2005, 26, 6984–6990. [Google Scholar] [CrossRef] [PubMed]
Ischiropoulos, H.; Zhu, L.; Beckman, J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 1992, 298, 446–451. [Google Scholar] [CrossRef] [PubMed]
Xie, Q.; Cho, H.; Calaycay, J.; Mumford, R.; Swiderek, K.; Lee, T.; Ding, A.; Troso, T.; Nathan, C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256, 225–228. [Google Scholar] [CrossRef] [PubMed]
O'Toole, G.; Kaplan, H.B.; Kolter, R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000, 54, 49–79. [Google Scholar] [CrossRef] [PubMed]
Riccio, D.A.; Dobmeier, K.P.; Hetrick, E.M.; Privett, B.J.; Paul, H.S.; Schoenfisch, M.H. Nitric oxide-releasing S-nitrosothiol-modified xerogels. Biomaterials 2009, 30, 4494–4502. [Google Scholar] [CrossRef] [PubMed]
Marxer, S.M.; Rothrock, A.R.; Nablo, B.J.; Robbins, M.E.; Schoenfisch, M.H. Preparation of nitric oxide (no)-releasing sol−gels for biomaterial applications. Chem. Mater. 2003, 15, 4193–4199. [Google Scholar] [CrossRef]
Nablo, B.J.; Schoenfisch, M.H. Antibacterial properties of nitric oxide-releasing sol-gels. J. Biomed. Mater. Res. Part A 2003, 67A, 1276–1283. [Google Scholar] [CrossRef]
Hetrick, E.M.; Schoenfisch, M.H. Antibacterial nitric oxide-releasing xerogels: Cell viability and parallel plate flow cell adhesion studies. Biomaterials 2007, 28, 1948–1956. [Google Scholar] [CrossRef] [PubMed]
Nablo, B.J.; Chen, T.Y.; Schoenfisch, M.H. Sol−Gel derived nitric-oxide releasing materials that reduce bacterial adhesion. J. Am. Chem. Soc. 2001, 123, 9712–9713. [Google Scholar] [CrossRef] [PubMed]
Nablo, B.J.; Rothrock, A.R.; Schoenfisch, M.H. Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants. Biomaterials 2005, 26, 917–924. [Google Scholar] [CrossRef] [PubMed]
Hogg, N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic. Biol. Med. 2000, 28, 1478–1486. [Google Scholar] [CrossRef] [PubMed]
Guyomard, A.; Dé, E.; Jouenne, T.; Malandain, J.J.; Muller, G.; Glinel, K. Incorporation of a hydrophobic antibacterial peptide into amphiphilic polyelectrolyte multilayers: a bioinspired approach to prepare biocidal thin coatings. Adv. Funct. Mate.l 2008, 18, 758–765. [Google Scholar] [CrossRef]
Shukla, A.; Fleming, K.E.; Chuang, H.F.; Chau, T.M.; Loose, C.R.; Stephanopoulos, G.N.; Hammond, P.T. Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials 2010, 31, 2348–2357. [Google Scholar] [CrossRef] [PubMed]
Hancock, R.E.W.; Diamond, G. The role of cationic antimicrobial peptides in innate host defences. Trends in Microbiology 2000, 8, 402–410. [Google Scholar] [CrossRef] [PubMed]
Ganz, T. The Role of antimicrobial peptides in innate immunity. Integr Comp Biol 2003, 43, 300–304. [Google Scholar] [CrossRef] [PubMed]
Chen, W.; McCarthy, T.J. Layer-by-Layer deposition: A tool for polymer surface modification. Macromolecules 1997, 30, 78–86. [Google Scholar]
Etienne, O.; Picart, C.; Taddei, C.; Haikel, Y.; Dimarcq, J.L.; Schaaf, P.; Voegel, J.C.; Ogier, J.A.; Egles, C. Multilayer Polyelectrolyte Films Functionalized by Insertion of Defensin: A New Approach to Protection of Implants from Bacterial Colonization. Antimicrob. Agents Chemother. 2004, 48, 3662–3669. [Google Scholar] [CrossRef] [PubMed]
Etienne, O.; Gasnier, C.; Taddei, C.; Voegel, J.C.; Aunis, D.; Schaaf, P.; Metz-Boutigue, M.H.; Bolcato-Bellemin, A.L.; Egles, C. Antifungal coating by biofunctionalized polyelectrolyte multilayered films. Biomaterials 2005, 26, 6704–6712. [Google Scholar] [CrossRef] [PubMed]
Humblot, V.; Yala, J.F.; Thebault, P.; Boukerma, K.; Héquet, A.; Berjeaud, J.M.; Pradier, C.M. The antibacterial activity of Magainin I immobilized onto mixed thiols Self-Assembled Monolayers. Biomaterials 2009, 30, 3503–3512. [Google Scholar] [CrossRef] [PubMed]
Izquierdo-Barba, I.; Vallet-Regí, M.; Kupferschmidt, N.; Terasaki, O.; Schmidtchen, A.; Malmsten, M. Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials 2009, 30, 5729–5736. [Google Scholar] [CrossRef] [PubMed]

© 2010 by the authors. Licensee MDPI, Basel, Switzerland. This article is an Open Access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/3.0/).

Share and Cite

MDPI and ACS Style

Wang, G.; Zreiqat, H. Functional Coatings or Films for Hard-Tissue Applications. Materials 2010, 3, 3994-4050. https://doi.org/10.3390/ma3073994

AMA Style

Wang G, Zreiqat H. Functional Coatings or Films for Hard-Tissue Applications. Materials. 2010; 3(7):3994-4050. https://doi.org/10.3390/ma3073994

Chicago/Turabian Style

Wang, Guocheng, and Hala Zreiqat. 2010. "Functional Coatings or Films for Hard-Tissue Applications" Materials 3, no. 7: 3994-4050. https://doi.org/10.3390/ma3073994

Article Menu

Functional Coatings or Films for Hard-Tissue Applications

Abstract

1. Introduction

2. Anti-corrosion and Anti-wear Coatings

2.1. Oxide Coatings

2.1.1. Thermal oxidation technique (TO)

2.1.2. Microarc oxidation (MAO)

2.1.3. Oxygen ion implantation

2.1.4. Sol-gel method

2.1.5. Thermal spraying technique

2.2. Nitride Coatings

2.3. Diamond-like Carbon (DLC) Films

3. Biocompatibility and Bioactivity

3.1. Hydroxyapatite (HA) Coatings

3.2. Bioactive Glass and Glass-ceramics Coatings

3.3 Bioactive Oxide Coatings

3.4. Bioactive Composite Coatings with Polymers

3.5. Biological Molecules Incorporated Bioactive Coatings

4. Antibacterial Coatings

4.1. Antibacterial Coatings with Inorganic Agents

4.2. Antibacterial Coatings with Antibiotics and Antibodies

4.3. Nitric Oxide-releasing Antibacterial Coatings

4.4. Antimicrobial Peptide Functionalized Films

5. Summary

Acknowledgements

References

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI